Luogo e data di nascita: Parma, 09 Settembre 1961
Residenza: via Vegri 54, Ferrara (Italia)
Codice Fiscale: FNRNRC61P09G337A
Affiliazione: Struttura Organizzativa Dipartimentale di Neuroradiologia, Dipartimento di Scienze Biomediche, Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze, Largo Brambilla 3, Firenze 50134, Italia
Telefono: +39-055-7948638
Fax: +39-055-7948325
e-mail doctor.arkadin@gmail.com, enrico.fainardi@unifi.it, fainardie@aou-careggi.toscana.it
11/07/1988: Laurea in Medicina e Chirurgia; Facoltà di Medicina e Chirurgia dell’Università degli Studi di Parma, Italia.
1988/Seconda sessione: Abilitazione all’esercizio della professione medica; Facoltà di Medicina e Chirurgia dell’Università degli Studi di Parma, Italia.
28/10/1992: Specializzazione in Neurologia con lode; Facoltà di Medicina e Chirurgia dell’Università degli Studi di Ferrara, Italia.
10/06/1998: Dottorato di Ricerca in “Discipline Neurologiche e Neurosensoriali”; Facoltà di Medicina e Chirurgia dell’Università degli Studi di Ancona, Italia.
02/01/1998-16/10/2001: Dirigente Medico, Unità Operativa di Neuroradiologia, Ospedale “M. Bufalini”-AUSL di Cesena, Italia.
30/10/2001: Specializzazione in Radiologia; Facoltà di Medicina e Chirurgia dell’Università degli Studi di Ferrara, Italia.
16/10/2001-31/01/2016: Dirigente Medico, Unità Operativa di Neuroradiologia, Dipartimento Attività Integrate (D.A.I.) di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria Arcispedale S.Anna, Ferrara, Italia.
2014: Ministero dell'Istruzione, della Sanità e della Ricerca; Abilitazione scientifica nazionale alle funzioni di professore di seconda fascia nel settore concorsuale 06/Il "Diagnostica per Immagini, Radioterapia e Neuroradiologia".
01/04/2017: Facoltà di Medicina e Chirurgia dell’Università degli Studi di Firenze, Italia; Professore Associato di Neuroradiologia (settore concorsuale 06/Il "Diagnostica per Immagini, Radioterapia e Neuroradiologia"; Settore Scientifico-Disciplinare MED 37 “Neuroradiologia”), Dipartimento di Scienze Biomediche, Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze.
2018: Ministero dell'Istruzione, della Sanità e della Ricerca; Abilitazione scientifica nazionale alle funzioni di professore di prima fascia nel settore concorsuale 06/Il "Diagnostica per Immagini, Radioterapia e Neuroradiologia".
01/02/2016-30/04/2017: Dirigente Medico, Direttore Facente Funzioni, Struttura Organizzativa Dipartimentale di Neuroradiologia, Dipartimento dei Servizi, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italia.
01/05/2017-oggi: Direttore Struttura Organizzativa Dipartimentale di Neuroradiologia, Dipartimento dei Servizi, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italia.
CURRICULUM VITAE ENRICO FAINARDI
e-mail henryfai@tin.it, enrico.fainardi@unifi.it, fainardie@aou-careggi.toscana.it
FORMAZIONE
1988-1994: Frequenza presso l’Istituto di Clinica Neurologica dell’Università degli Studi di Ferrara, Italia.
06/11/1995-18/11/1995: Frequenza presso il Laboratorio di Neurochimica dell’Università di Göttingen, Germania, diretto dal Prof. Hansotto Reiber.
27/09/1996-05/10/1996: Frequenza presso il Laboratorio di Neurochimica dell’Università di Göttingen, Germania, diretto dal Prof. Hansotto Reiber.
07/07/1997-11/07/1997: Corso Residenziale in Neuroimmunologia, Primo Corso Avanzato. Vienna, Austria, tenuto dal Prof. Hans Lassmann.
17/03/1999-20/03/1999: Corso Base per Neuroradiologi. Ospedale San Raffaele, Milano, Italia, organizzato dal Prof. Giuseppe Scotti.
17/03/1999-20/03/1999: Primo Corso Residenziale di Neuroimmunologia, Bergamo, Italia, organizzato dal Dott. Gianvito Martino.
25/10/2000-26/10/2000: Corso Base-Avanzato di Risonanza Magnetica, Istituto di Scienze Radiologiche dell’Università degli Studi dell’Università di Parma, Italia, organizzato dal Prof. Paolo Pavone.
17/03/2004-20/03/2004: Sesto Corso Residenziale di Neuroimmunologia, Bergamo, Italia, organizzato dal Dott. Gianvito Martino.
27/09/2004-28/09/2004: 5° Corso della European School of Neuroimmunology. Venezia, Italia.
17/05/2009 al 24/05/2009: Frequenza presso il Dipartimento di Radiologia dell’Ospedale di Tulln, Austria, Università di Vienna, Austria, diretto dal Prof. Christian Năsel.
17/12/2009-19/12/2009: Frequenza presso il Centro Sclerosi Multipla ed il Servizio di Radiodiagnostica e Scienza delle Immagini della Fondazione Don Carlo Gnocchi di Milano, diretto dal Dott. Marco Rovaris.
25/04/2011-29/04/2011: Frequenza presso il Department of Medical Imaging, Lawson Health Research Institute and Imaging Research Lab, Robarts Research Institute, Western University, London, Ontario, Canada, diretto dal Prof. Ting Lee.
28/09/2015-29/09/2015: Frequenza presso la Stroke Unit, Hospital Universitari Vall d’Hebron, Barcelona, Spagna, diretta dal Dott. Carlos Molina.
14/10/2015-16/10/2015: Frequenza presso il Department of Medical Imaging, Lawson Health Research Institute and Imaging Research Lab, Robarts Research Institute, Western University, London, Ontario, Canada, diretto dal Prof. Ting Lee.
19/10/2015-30/10/2015: Frequenza presso il Calgary Stroke Program, Department of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, Alberta, Canada, Professor Bijoy Menon.
CARRIERA/IMPIEGO
1993-1994: AUSL di Ferrara, Italia; specialista neurologo ambulatoriale (in qualità di sostituto).
02/01/1993-30/09/1993: Istituto di Clinica Neurologica dell’Università degli Studi di Ferrara, Italia; incarico libero professionale di ricerca scientifica, fondo per la Ricerca Sanitaria Finalizzata, Regione Emilia-Romagna, “Studio clinico-epidemiologico di evoluzione e prognosi e prognosi della Sclerosi Multipla nella provincia di Ferrara”.
04/10/1994-31/10/1994: Istituto di Clinica Neurologica dell’Università degli Studi di Ferrara, Italia; incarico libero professionale di ricerca scientifica, fondo per la Ricerca Sanitaria Finalizzata, Regione Emilia-Romagna, “Studio clinico-epidemiologico di evoluzione e prognosi e prognosi della Sclerosi Multipla nella provincia di Ferrara”
1996: INAIL di Ferrara, Italia; specialista neurologo ambulatoriale (in qualità di sostituto),
16/10/2001-31/01/2016: come dirigente medico di Neuroradiologia del Dipartimento Attività Integrate (D.A.I.) Neuroscienze/Riabilitazione presso l’Azienda Ospedaliero-Universitaria di Ferrara:
a) svolge e partecipa in maniera continuativa all’attività diagnostica ed assistenziale occupandosi di TC, RM e AGF nelle patologie neurologiche e neurochirurgiche cranio-encefaliche e vertebro-midollari, inclusa l’attività di pronta disponibilità come reperibile nei giorni feriali e festivi;
b) stabilisce rapporti periodici e stabili con gli specialisti afferenti alla Neuroradiologia come Neurologi, Neurochirurghi, Oculisti, Audiologi, specialisti di Otorinolaringoiatria e Chirurghi Maxillo-Facciali.
c) fa parte dello Stroke Team dell’Azienda Ospedaliero-Universitaria di Ferrara ed è uno dei coautori del PDTA dell’ictus ischemico acuto.
d) partecipa al coordinamento delle attività cliniche, diagnostiche e terapeutiche legate ai tumori cerebrali comprendenti riunioni interdisciplinari periodiche settimanali dedicate alla discussione dei casi clinici.
ESPERIENZE DI INSEGNAMENTO
2001-2016: Professore a contratto di Neuroradiologia nella Specialità di Neurochirurgia, Università degli Studi di Ferrara, Italia.
2001-2016: Professore a contratto di Neuroradiologia nella Specialità di Medicina Interna, Università degli Studi di Ferrara, Italia.
2003-2016: Professore a contratto di Neuroimmunologia nella Specialità di Neurologia, Università degli Studi di Ferrara, Italia.
2010-2016: Professore a contratto di Neuroradiologia nella Specialità di Radiologia, Università degli Studi di Ferrara, Italia.
2012-2016: Professore a contratto di Neuroradiologia nella Specialità di Malattie Infettive, Università degli Studi di Ferrara, Italia.
2017-oggi: Professore di Neuroradiologia nel Corso di Laurea di Medicina e Chirurgia, Università degli Studi di Firenze, Italia.
2017-oggi: Professore di Neuroradiologia nella Specialità di Radiologia, Università degli Studi di Firenze, Italia.
2017-oggi: Professore di Neuroradiologia nella Specialità di Neurologia, Università degli Studi di Firenze, Italia.
2017-oggi: Professore di Neuroradiologia nella Specialità di Neurochirurgia, Università degli Studi di Firenze, Italia.
ESPERIENZE/COLLABORAZIONI DI RICERCA
20/12/2000-31/01/2016: Laboratorio di Neurochimica, Clinica Neurologica dell’Università degli Studi di Ferrara, Italia.
1997-oggi: Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Institute, Milano, Italia, diretto dal Dott. Roberto Furlan. 02/01/1998-16/10/2001: Unità Operativa di Neurochirurgia per la Traumatologia, Ospedale “M. Bufalini” - AUSL di Cesena, Italia, diretta dal Dott. Franco Servadei.
02/01/1998-16/10/2001: Unità Operativa di Anestesia e Rianimazione, Ospedale “M. Bufalini” - AUSL di Cesena, Italia.
2005-2012: Dipartimento di Radiologia, Ospedale di Tulln, Università di Vienna, Austria, diretto dal Prof. Christian Năsel.
2009-oggi: Centro Sclerosi Multipla ed il Servizio di Radiodiagnostica e Scienza delle Immagini, Fondazione Don Carlo Gnocchi, Milano, Italia, diretto dal Dott. Marco Rovaris.
2010-oggi: Department of Medical Imaging, Lawson Health Research Institute and Imaging Research Lab, Robarts Research Institute, Western University, London, Ontario, Canada, diretto dal Prof. Ting Yim Lee.
2011-oggi: Laboratorio di Oncologia, Istituto Scientifico G. Gaslini, Genova, Italia, diretto dal Prof. Vito Pistoia.
2011-2015: Laboratorio di Cardiologia, Divisione di Cardiologia, Università di Ginevra, Svizzera, diretto dal Prof. François Mach.
2012-oggi: Institut Universitarie d’Hèmatologie, Service de Recherches en Hemato-Immunologie, Hòpital Saint-Louis, Parigi, Francia, diretto dal Prof. Edgardo Carosella.
2012-oggi: Dipartimento per le malattie neurologiche immuno-mediate, Clinica Neurologica, Università di Belgrado, Serbia.
2013-2017: Calgary Stroke Program, Department of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, Alberta, Canada, Professor Bijoy Menon.
2015-oggi: Dipartimento di Medicina e Specialità Mediche, Università degli Studi di Genova, Italia, Professor Fabrizio Montecucco.
2015-oggi: Istituto di Ricerche Farmacologiche Mario Negri, Centro di Ricerche Cliniche per le Malattie Rare “Aldo e Cele Daccò”, Bergamo, Italia, Dott. Guido Bertolini.
INCARICHI PROFESSIONALI
2009: 5th International Conference on HLA-G, Paris (France): membro dello Scientific Advisory Board
2012: 6th International Conference on HLA-G, Paris (France): membro dello Scientific Advisory Board
2015: 7th International Conference on HLA-G, Paris (France): membro dello Scientific Advisory Board
2012-2016: Referente della Ricerca del Dipartimento Attività Integrate (D.A.I.) Neuroscienze/Riabilitazione presso l’Azienda Ospedaliero-Universitaria di Ferrara con i seguenti compiti:
a) supporto per l’elaborazione dei piani aziendali per la ricerca e l’innovazione;
b) osservazione sul potenziale impatto di carattere organizzativo, gestionale, etico delle iniziative di ricerca sull’operatività dei servizi;
c) supporto alla funzione propositiva del Collegio di Direzione Aziendale;
d) valutazione degli studi spontanei;
e) collaborazione per l’elaborazione di indirizzi per la formazione alla ricerca e di criteri per il supporto alla ricerca spontanea.
2013-2016: Incarico Professionale di Alta Specializzazione “Tecniche avanzate TC e RM in neuroradiologia”
SOVVENZIONI PER LA RICERCA
2007-2010: Nuove conoscenze e problematiche assistenziali nell’ictus cerebrale: un programma strategico di ricerca e sviluppo-Studio dei marker biologici, neurofisiologici, e Neuroradiologici associati all’ictus ischemico (come coordinatore scientifico); Ministero della Salute, Italia; finanziamento erogato = 51.000,00 Euro.
2008-2011: A primary brain tumours registry as a framework for promoting clinical research in Neuro-Oncology: Project of Emilia-Romagna region on Neuro-Oncology (PERNO)-Prognostic value of neuroradiological examinations in primary brain tumours (come coordinatore scientifico); Regione Emilia Romagna, Italia; 105.000,00 Euro.
2009-2010:Molecular and humoral immune characterization of Epstein-Barr virus brain persistence and its peripheral T cell regulatory mechanisms in multiple sclerosis (come investigatore principale); FISM (Fondazione Italiana Sclerosi Multipla); finanziamento erogato = 45.000,00 Euro.
2012-2014: Evolution of Cerebral Hemodynamics and Blood-Brain Barrier Disturbances After Acute Ischemia Stroke: A CT Perfusion Imaging Study, (come co-investigatore principale); European Stroke Network (ESN)/Canadian Stroke Network (CSN);finanziamento erogato = 23.500,00 Euro.
2015-2017: “Precise and Rapid assessment of collaterals using multi-phase CTA in the triage of patients with acute ischemic stroke for IA Therapy (“PRove-IT”)”, (come co-investigatore principale); University of Calgary, Alberta, Canada;finanziamento erogato = 20.000,00 Euro.
PREMI E ONOREFICENZE
1993: vincitore del premio di studio in memoria dell’Architetto Andrea Donati per i giovani medici: Istituto di Clinica Neurologica, Università degli Studi di Ferrara, Italia.
2003: titolo di “Cultore della Materia” in Neurologia, Università degli Studi di Ferrara, Italia.
SOCIETA’ PROFESSIONALI
1995-oggi: membro del “European Quality Assurance Scheme” for oligoclonal bands in cerebrospinal fluid analysis. Londra, Inghilterra.
1996-oggi: membro del “CSF Research Group of the World Federation of Neurology”.
1998-oggi: aderente al “External Quality Assessment-Cerebrospinal Fluid Survey”, Göttingen, Germania.
1998-oggi. membro della Associazione Italiana Neuroimmunologia (AINI)
2006-oggi: coordinatore regionale della Associazione Italiana Neuroimmunologia (AINI)
2007-oggi: membro del “BioMS-eu Consortium for CSF Biomarker research in MS”.
2013-oggi: membro della Società Italiana di Radiologia Medica (SIRM)
2016-oggi: membro della Associazione Italiana di Neuroradiologia (AINR)
2016-oggi: membro della Italian Stroke Organization (ISO)
REVISORE PER
a) American Journal of Neuroradiology
b) Annals of Neurology
c) BMC Neurology
d) British Medical Journal Open
e) Clinica Chimica Acta
f) Clinical Biochemistry
g) DNA and cell Biology
h) European Journal of Neurology
i) European Radiology
j) Frontiers in Neurology
k) Human Immunology
l) Intensive Care Medicine
m) Journal of Infection
n) Journal of Neurointerventional Surgery
o) La radiologia Medica
p) Neurological Sciences
q) Neuroradiology
r) The Journal of Neurological Sciences
LETTURE SU INVITO
139 Letture ad invito fra cui (53° Congresso Società Italiana di Neurologia SIN 2023):
1) Neuroimaging nel monitoraggio del paziente neurologico cronico. Malattie vascolari. 53° Congresso Società Italiana di Neurologia (SIN). Napoli 21-24 Ottobre 2023.
2) Intelligenza artificiale in neuroradiologia: quale futuro nella pratica clinica quotidiana? 32° Congresso Nazionale della Società Italiana di Neuroradiologia (AINR). Bergamo 18-21 Ottobre 2023.
3) Inflammatory immune-modulation of brain AVMs. Campo Base NeuroVascolare. Roma, 20-22 Settembre 2023.
4) Perfusion imaging and automated softwares. European Stroke Organisation (ESO) Summer School. L’Aquila 4-8 Settembre 2023.
5) Diagnostica neuroimaging. Italian Stroke Association-Associazione Italiana Ictus (ISA-AII) Summer School. Roma 19-23 Giugno 2023.
6) Evoluzione degli ematomi intraparenchimali: fattori prognostici e destino dell'area periematoma Italian Stroke Association-Associazione Italiana Ictus (ISA-AII) Summer School. Roma 19-23 Giugno 2023.
7) Imaging avanzato e circoli collaterali per la selezione a 6-24 ore: il punto di vista del Neuroradiologo. 9° Congresso Nazionale sull’ictus cerebrale. Italian Stroke Association-Associazione Italiana Ictus (ISA-AII). Lecce 30 Marzo-1 Aprile 2023.
8) Strumenti radiologici per la selezione dei pazienti: evidenze e controversie. Riunione Regionale ANEU Toscana. Pistoia 18 Novembre 2022.
9) Neuroimaging e Neurointerventistica: Aree Vaste a confronto. La rete di AV Centro. Tuscany Stroke Network. Regione Toscana. Firenze 27 Ottobre 2022.
10)How to select patients to treat? Campo Base NeuroVascolare. Roma, 28-30 Settembre 2022.
11)Le neuroimmagini nella rete dell’ictus emorragico. Le reti delle neuroscienze ospedaliere e territoriali. V Meeting delle Neuroscienze Toscane. Società dei Neurologi, Neurochirurghi e Neuroradiologi Ospedalieri (SNO). Sociatà Italiana di Neurologia (SIN). Firenze 15-17 Settembre 2022.
12)Diagnostica neuroimaging. Italian Stroke Association-Associazione Italiana Ictus (ISA-AII) Summer School. Roma 4-8 Luglio 2022.
13)Evoluzione degli ematomi intraparenchimali: fattori prognostici e destino dell'area periematomaItalian Stroke Association-Associazione Italiana Ictus (ISA-AII) Summer School. Roma 4-8 Luglio 2022.
14)L’imaging in fase acuta. Serve qualcosa di più? NEURONS 2022 - Neurocritical Care and Management Symposium. Palermo 30 giugno-1 luglio 2022.
15)La barriera emato-encefalica. Campo Base Anatomia NeuroVascolare. Cosenza, 23-25 Giugno 2022.
16)Imaging vascolare avanzato: uso clinico. Sofware di perfusione. 31° Congresso Nazionale della Società Italiana di Neuroradiologia (AINR). Roma, 8-11 Giugno 2022.
17)I software automatici nella gestione dello stroke: prospettive future. Sardinia Spine 2022… and Stroke. Cagliari, 1-3 Giugno 2022.
18)Non-anatomic: Functional advanced imaging in the selection for reperfusion therapies in stroke patients.XXII Symphosium Neuroradiologicum (SNR) -American Society of Neuroradiology (ASNR) 2022 Meeting. New York, 14-16 Maggio 2022.
19)I software automatici per il calcolo del target mismatch sono intercambiabili? Stroke 2021. 8° Congresso Nazionale sull’Ictus Cerebrale. Verona 10-13 Dicembre 2021.
20)Ematomi intraparenchimali. Stroke 2021. 8° Congresso Nazionale sull’Ictus Cerebrale. Verona 10-13 Dicembre 2021.
21)Perfusione nell’ictus ischemico, utile, superflua o indispensabile? Quali mappe, quali informazioni, quali problemi? Corso Itinerante di Neuroradiologia (AINR). Torino 22-23 Novembre 2021.
22)Introduzione: un’overview sulla letteratura. LX Congresso Nazionale della Società dei Neurologi, Neurochirurghi e Neuroradiologi Ospedalieri (SNO). Cagliari, 17-20 Novembre 2021.
23)L’imaging in acuto e nel follow-up. 122° Congresso Nazionale della Società Italiana di Medicina Interna (SIMI). 22-24 Ottobre 2021.
24)Advanced Neuroimaging in stroke clinical practice. TReeS Translational Research on Stroke. Ictus: dal laboratorio al letto del malato. Corso FAD - Webinar. 19 Ottobre 2021.
25)Casi “perduti” (lowASPECTS): criteri di inclusione e indicatori neuroradiologici per la craniotomia decompressiva. 70° Congresso Nazionale Società Italiana di Neurochirurgia (SINch). Milano, 14-16 Ottobre 2021.
26)L’impatto dei software automatici nella gestione dello stroke. Griboi Sardinia Spine 2021… and Stroke Joint Meeting. Cagliari, 8-10 Settembre 2021.
27)Selezione terapeutica del paziente: awake stroke e paziente oltre le 6h. Ottobrate Neuroradiologiche Romane. 1° modulo - 15 Dicembre 2020/16 Gennaio 2021.
28)Imaging automatizzato dalla ripefusione critica. Modulo 2. Stroke 2020, 7° Congresso Nazionale sull’Ictus Cerebrale. 18 Dicembre 2020.
29)Fisiopatologia ed applicazione nell’ictus ischemico acuto. Sessione 5. Il punto sulla TC perfusionale. Cinque Giornate dell’AINR Virtual. Neuroradiologia Pediatrica e Funzionale. 4 Dicembre 2020.
30)TC Perfusionale nell’ictus ischemico acuto. Angels. Modulo Neuroimaging avanzato. Online Training Neuroradiologia Vascolare. 1 Dicembre 2020.
31)Le Linee Guida ISO-SREAD: Novità sui trattamenti di rivascolarizzazione. Stroke 2020, 7° Congresso Nazionale sull’Ictus Cerebrale. 15 Ottobre 2020.
32)Metodiche avanzate: core, penombra e circoli collaterali. Deep Learning di Neuroradiologia. 49° Congresso SIRM. 2 Ottobre 2020.
33)Perfusione TC nell’ictus: come farla e come interpretarla. AINR Online Academy. 11 Giugno 2020.
34)Per il neuroradiologo time is relative. Congresso SIAARTI NEUROcritical care and maNagement Symposium (NEURONS). Padova, 13-14 Febbraio 2020.
35)Neuroimaging multimodale. XXVIII Congresso Nazionale della Società Italiana Interdisciplinare NeuroVascolare (SINV). Ferrara, 28-29 Novembre 2019.
36)Ruolo dei circoli collaterali e della TC perfusionale nella selezione del paziente con stroke databile entro 24 ore. XIX Congresso Nazionale della Società Italiana per lo Studio dello Stroke. Francavilla al Mare, 14-15-16 Novembre 2019.
37)Actualizacíon TC multimodal ictus. Reunión Anual de la Sociedad Española de Neurorradiología. Santander, España. 24-26 Ottobre 2019.
38)TC Multimodal como predictor de respuesta al tratamiento. XLVIII Reunión Anual de la Sociedad Española de Neurorradiología. Santander (España), 24-26 Ottobre 2019.
39)Le neuroimmagini e la possibilità di estendere la finestra terapeutica. 50° Congresso della Società Italiana di Neurologia (SIN). Bologna, 12-15 Ottobre 2019.
40)La penombra in TC Perfusion e il circolo collaterale in AngioTC multifasica. Campo Base NeuroVascolare. Firenze, 25-28 Settembre 2019.
41)Neurological implication of HLA-G. 8th Internation Conference on HLA-G. Paris (France), 8-10 Luglio 2019.
42)Anatomia e fisiologia della barriera emato-encefalica. Campo Base Anatomia NeuroVascolare. Cosenza, 27-29 Giugno 2019.
43)Circoli collaterali e studio di perfusione nell’ictus ischemico. Urgenze Neuroradiologiche. Pescara, 17 Maggio 2019.
44)Circoli collaterali e perfusione TC: selezione avanzata, riperfusione e permeabilità della barriera emato-encefalica. 1° Corso di Neuroradiolgia Toscana. Aggiornamento sull’ictus ischemico acuto. Firenze, 22 Marzo 2019.
45)Cosa può dirci l’imaging avanzato nello stroke ischemico. Neurons-Neurocritical Care and Management Symphosium. ACCMED-Accademia Nazionale di Medicina. Genova, 28 Febbraio-1 Marzo 2019.
46)Perfusione TC. Imaging Avanzato in Neuroradiologia. Napoli, 3-5 Dicembre 2018.
47)Ruolo delle neuroimmagini nella selezione dei pazienti candidati a rivascolarizzazione meccanica. XLIX Congresso della Sociatà Italiana di Neurologia (SIN). Roma, 27-30 Ottobre 2018.
48)Il neuroimaging nella fase iperacuta dell’ictus ischemico. Dalle sindromi alle malattie neurologiche. Ricerca traslazionale, appropriatezza diagnostica e terapeutica. II Meeting delle Neuroscienze Toscane. Società dei Neurologi, Neurochirurghi e Neuroradiologi Ospedalieri (SNO). Sociatà Italiana di Neurologia (SIN). Firenze 6-8 Aprile 2018.
49)Circoli collaterali angio-TC e TC perfusionale: dibattito ancora aperto. Il parere del diagnosta. Ictus Ischemico Acuto. Società Italiana di Radiologia Medica e Interventistica. Sezione di Studio Neuroradiologia in collaborazione con il Collegio dei Professori Universitari di Neuroradiologia. Roma, 26 Giugno 2018.
50)Criteri di selezione per la trombolisi meccanica. Neuroradiologia tra perfusione e circoli collaterali. STROKE 2017. 5° Congresso Nazionale sull’Ictus Cerebrale. The Italian Stroke Organization (I.S.O.). Roma, 28 Febbraio-2 Marzo 2018.
51)Il neuroimaging nella fase iperacuta dell’ictus ischemico. Il Meeting delle Neuroscienze Toscane. Firenze, 6-8 Aprile 2018.
52)Stroke 2017: Nuovi criteri di selezione e target terapeutici. 29° Congresso Nazionale Associazione Italiana di Neuroradiologia (AINR) 2017. Milano, 27-30 Settembre 2017.
53)Trauma Cranico Grave: TAC e RMN precoce: 13° Congresso Nazionale SIARED 2017. Roma, 25-27 Maggio 2017.
54)Diagnostica della perfusione e dei circoli collaterali. 57° Congresso Nazionale della Società dei Neurologi, Neurochirurghi e Neuroradiologi Ospedalieri (SNO). Napoli, 24-26 Maggio 2017.
55)Cranio-encefalo. La “Malattia Trauma” dall‛imaging alla gestione. Firenze, 17 Marzo 2017.
56)Ruolo della Tomografia computerizzata. STROKE 2017. 4° Congresso Nazionale sull’Ictus Cerebrale. The Italian Stroke Organization (I.S.O.) Napoli, 1 marzo 2017.
57)Imaging dell'ESA e del vasospasmo post-ESA. Campo Base NeuroVascolare. Firenze, 28 Settembre 2016.
58)Update in TC-indicazione alla terapia. Quattordicesimo Corso di Neuroradiologia Interventistica. “Stroke: una gestione multidisciplinare”. Salerno, 10 Giugno 2016.
59)La TC cerebrale nei traumi cranici: aspetti diagnosticie prognostici. CREACTIVE imaging: corso teorico-pratico sulla lettura della TC cerebrale. Milano, 18 Dicembre 2015.
60)La selezione del paziente con TC-Perfusion; CT-Perfusion based patient selection in acute ischemic stroke. Campo Base NeuroVascolare. Firenze, 8 Ottobre 2015.
61)HLA-G in different brain disorders including MS.Seventh International Conference on HLA-G. Paris (France), 6 Luglio 2015.
62)Il concetto di mismatch in TC di perfusione come target della ricanalizzazione. Stroke 2015 2° congresso nazionale sull’ictus cerebrale. ISO Italian Stroke Organization. Firenze, 19 Febbraio 2015.
63)Penombra ischemica e alterazioni della barriera emato-encefalica in TC-Perfusion. 53° Congresso Nazionale della Società dei Neurologi, Neurochirurghi e Neuroradiologi Ospedalieri (SNO). Firenze, 16 Maggio 2013.
64)Studio neuroradiologico in acuto: vantaggi e svantaggi. XXI Congresso Nazionale della Società Italiana Interdisciplinare NeuroVascolare (SINV). Ferrara, 22-23 Novembre 2019.
65)HLA-G in autoimmune and inflammatory diseases. 6th Internation Conference on HLA-G. Paris (France), 9 Luglio 2012.
66)The role of sHLA-G in multiple sclerosis.Fifth International Conference on HLA-G. Paris (France), 8 Luglio 2009.
67)Studi neuroradiologici nel trauma: TAC e Risonanza. Corso Introduttivo. Neurorianimazione. Milano, SMART 2009, 5 Maggio 2009.
68)Perfusion abnormalities associated to spontaneous intracerebral hemorrhage. 9th International Conference on XeCT and related CBF techniques. Kusadasi (Turkey), 5 Settembre 2008.
69)Il flusso ematico cerebrale negli ematomi e nelle neoplasie cerebrali. Annual Neuromeeting 2008. Siena, 9 Maggio 2008.
70)Imaging funzionale: Xe-CT.Convegno “Trauma: update. Il monitoraggio della sofferenza tissutale cerebrale: indicazioni, tecniche, interpretazione”. Parma, 11 Aprile 2008.
71)Diagnostica radiologica nel danno diffuso da trauma cranico.Convegno “Trauma: update and organization” 3° Edizione. Bologna, 15 Febbraio 2008.
72)Cerebrospinal fluid levels of soluble HLA-G molecules in multiple sclerosis. 4th International Conference on HLA-G. Paris (France), 12 Luglio 2006.
73) The involvement of Chlamydia pneumoniae in multiple sclerosis.16th European Congress of Clinical Microbiology and Infectious Diseases. Nice (France), 2 Aprile 2006.
PUBBLICAZIONI
H Index
Scopus (Settembre 2023): 35
Contributi scientifici (abstracts):
260 contributi scientifici a Congressi Nazionali ed Internazionali
Pubblicazioni scientifiche su Riviste Nazionali ed Internazionali:
263 pubblicazioni scientifiche su riviste Nazionali ed Internazionali:
1) Busto G, Scola E, Fainardi E. Computed tomography perfusion ischemic core underestimation: a perfusion scotoma case. Neurol Sci 2023 Oct 2 3[Online ahead of print].
2)Fainardi E, Busto G, Morotti A. Automated advanced imaging in acute ischemic stroke. Certainties and uncertainties. Eur J Radiol Open 2023; 11: 100524.
3) Pezzini D, Nawabi J, Schlunk F, Li Q, Mazzacane F, Busto G, Scola E, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Cavallini A, Katsanos AH, Shoamanesh A, Zini A, Casetta I, Fainardi E, Morotti A, Padovani A. Predictors and prognostic impact of hematoma expansion in infratentorial cerebral hemorrhage. Neurocrit Care 2023 Sep 5 [Online ahead of print].
4) Lotti A, Barilaro A, Mariottini A, Vannozzi L, Piergentili M, Fainardi E, Massacesi L. Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management. Front Neurol 2023;14: 1201643.
5) Morotti A, Boulouis G, Nawabi J, Li Q, Charidimou A, Pasi M, Schlunk F, Shoamanesh A, Katsanos AH, Mazzacane F, Busto G, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Warren AD, Laudisi M, Cavallini A, Gurol E, Viswanathan A, Zini A, Casetta I, Fainardi E, Greenberg SM, Padovani A, Rosand J, Goldstein J. Association between hematoma expansion severity and outcome and its interaction with baseline intracerebral hemorrhage volume. Neurology 2023 Aug 21 [Online ahead of print].
6) Mariottini A, Lotti A, Innocenti C, Repice AM, Nozzoli C, Boncompagni R, Fainardi E, Saccardi R, Massacesi L. Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation. Eur J Neurol 2023 Jul 22 [Online ahead of print].
7) Rebchuk AD, Hill MD, Goyal M, Demchuk A, Coutts SB, Asdaghi N, Dowlatshahi D, Holodinsky JK, Fainardi E, Shankar J, Najm M, Rubiera M, Khaw AV, Qiu W, Menon BK, Field TS. Exploring sex differences for acute ischemic stroke clinical, imaging, and thrombus characteristics in the INTERRSeCT study. J Cereb Blood Flow Metab 2023 Jul 17 [Online ahead of print].
8)Cappellari M, Pracucci G, Saia V, Fainardi E, Casetta I, Sallustio F, Ruggiero M, Longoni M, Simonetti L, Zini A, Lazzarotti GA, Giannini N, Da Ros V, Diomedi M, Vallone S, Bigliardi G, Limbucci N, Nencini P, Ajello D, Marcheselli S, Burdi N, Boero G, Bracco S, Tassi R, Boghi A, Naldi A, Biraschi F, Nicolini E, Castellan L, Del Sette M, Allegretti L, Sugo A, Buonomo O, Dell'Aera C, Saletti A, De Vito A, Lafe E, Mazzacane F, Bergui M, Cerrato P, Feraco P, Piffer S, Augelli R, Vit F, Gasparotti R, Magoni M, Comelli S, Melis M, Menozzi R, Scoditti U, Cavasin N, Critelli A, Causin F, Baracchini C, Guzzardi G, Tarletti R, Filauri P, Orlandi B, Giorgianni A, Cariddi LP, Piano M, Motto C, Gallesio I, Sepe FN, Romano G, Grasso MF, Pauciulo A, Rizzo A, Comai A, Franchini E, Sicurella L, Galvano G, Mannino M, Mangiafico S, Toni D, On Behalf Of The Iretas Group. IV thrombolysis plus thrombectomy versus IV thrombolysis alone for minor stroke with anterior circulation large vessel occlusion from the IRETAS and Italian SITS-ISTR cohorts. Neurol Sci 2023 Jul 17 [Online ahead of print].
9) Cappellari M, Saia V, Pracucci G, Casetta I, Fainardi E, Sallustio F, Ruggiero M, Romoli M, Simonetti L, Zini A, Lazzarotti GA, Orlandi G, Vallone S, Bigliardi G, Renieri L, Nencini P, Semeraro V, Boero G, Bracco S, Tassi R, Castellano D, Naldi A, Biraschi F, Nicolini E, Del Sette B, Malfatto L, Allegretti L, Tassinari T, Tessitore A, Ferraù L, Saletti A, De Vito A, Lafe E, Cavallini A, Bergui M, Bosco G, Feraco P, Bignamini V, Mandruzzato N, Vit F, Mardighian D, Magoni M, Comelli S, Melis M, Menozzi R, Scoditti U, Cester G, Viario F, Stecco A, Fleetwood T, Filauri P, Sacco S, Giorgianni A, Cariddi LP, Piano M, Motto C, Gallesio I, Sepe F, Romano G, Grasso MF, Lozupone E, Fasano A, Comai A, Franchini E, Bruni S, Silvestrini M, Chiumarulo L, Petruzzelli M, Pavia M, Invernizzi P, Puglielli E, Casalena A, Pedicelli A, Frisullo G, Amistà P, Russo M, Allegritti M, Caproni S, Mangiafico S, Toni D; IRETAS Group. Stroke with large vessel occlusion in the posterior circulation: IV thrombolysis plus thrombectomy versus IV thrombolysis alone. J Thromb Thrombolysis 2023 Jun 28 [Online ahead of print].
10) Busto G, Morotti A, Carlesi E, Fiorenza A, Di Pasquale F, Mancini S, Lombardo I, Scola E, Gadda D, Moretti M, Miele V, Fainardi E. Pivotal role of multiphase computed tomography angiography for collateral assessment in patients with acute ischemic stroke. Radiol Med 2023; 128: 944-959.
11) Cappellari M, Pracucci G, Saia V, Sallustio F, Casetta I, Fainardi E, Capasso F, Nencini P, Vallone S, Bigliardi G, Saletti A, De Vito A, Ruggiero M, Longoni M, Semeraro V, Boero G, Silvagni U, Stancati F, Lafe E, Mazzacane F, Bracco S, Tassi R, Comelli S, Melis M, Romano D, Napoletano R, Menozzi R, Scoditti U, Chiumarulo L, Petruzzelli M, Vinci SL, Ferraù L, Taglialatela F, Zini A, Sanna A, Tassinari T, Iacobucci M, Nicolini E, Bergui M, Cerrato P, Giorgianni A, Princiotta Cariddi L, Amistà P, Russo M, Gallesio I, Sepe F, Comai A, Franchini E, Filauri P, Orlandi B, Besana M, Giossi A, Lazzarotti GA, Orlandi G, Castellano D, Naldi A, Plebani M, Zivelonghi C, Invernizzi P, Mangiafico S, Toni D. Predictors for hemorrhagic transformation and cerebral edema in stroke patients with first-pass complete recanalization. Int J Stroke 2023 Jun 19 [Online ahead of print].
12) Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D, Mancini S, Carlesi E, Moretti M, Desideri I, Muscas G, Della Puppa A, Fainardi E. Conventional and advanced magnetic resonance imaging assessment of non-enhancing peritumoral area in brain tumor. Cancers 2023; 15: 2992.
13) Sperti M, Arba F, Acerbi A, Busto G, Fainardi E, Sarti C. Determinants of cerebral collateral circulation in acute ischemic stroke due to large vessel occlusion. Front Neurol 2023; 14: 1181001.
14) Gentile L, Pracucci G, Saia V, Falcou A, Biraschi F, Zini A, Simonetti L, Riva L, Bigliardi G, Vallone S, Nencini P, Limbucci N, Diomedi M, Da Ros V, Longoni M, Ruggiero M, Tassinari T, Allegretti L, Cerrato P, Rubino E, Bergui M, Cavallo R, Naldi A, Comelli C, Cappellari M, Zivelonghi C, Plebani M, De Vito A, Merli N, Saletti A, Musolino RF, Ferraù L, Vinci SL, Sacco S, Orlandi B, De Santis F, Filauri P, Ruiz L, Sepe FN, Gallesio I, Petruzzellis M, Chiumarulo L, Sangalli D, Salmaggi A, Filizzolo M, Moller J, Melis M, Comelli S, Magoni M, Gilberti N, Gasparotti R, Invernizzi P, Pavia M, Pinto V, Laspada S, Marcheselli S, Ajello D, Viaro F, Baracchini C, Causin F, Giannini N, Caselli MC, Mancuso M, Cosottini M, Scoditti U, Menozzi R, Russo M, Amistá P, Napoletano R, Romano DG, Tassi R, Bracco S, Carimati F, Versino M, Giorgianni A, De Boni A, Fasano A, Barbarini L, Paladini A, Franchini E, Dall'Ora E, Comai A, Giovanni F, Pedicelli A, Sallustio F, Casetta I, Fainardi E, Mangiafico S, Toni D; Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS) Collaborators. Mechanical thrombectomy in patients with heart failure: the Italian registry of Endovascular Treatment in Acute Stroke. Neurol Sci 2023 May 18 [Online ahead of print].
15) Cappellari M, Saia V, Pracucci G, Fainardi E, Casetta I, Sallustio F, Nencini P, Bigliardi G, Saletti A, Ruggiero M, Da Ros V, Castellan L, Tassi R, Mandruzzato N, Toni D, Mangiafico S; IRETAS group. Predictors for clinical and functional outcomes in stroke patients with first-pass complete recanalization after thrombectomy. Eur J Neurol 2023; 30: 2288-2296.
16) Fainardi E, Busto G, Scola E, Casetta I, Mizutani K, Consoli A, Boulouis G, Padovani A, Morotti A. Perfusion gradients promote delayed perihaematomal oedema in intracerebral haemorrhage. Brain Commun 2023; 5: fcad133.
17) Chen ZF, Zhang L, Carrington AM, Thornhill R, Miguel O, Auriat AM, Fard NO, Hiremath S, Tshemeister Abitbul V, Dowlatshahi D, Demchuk A, Gladstone D, Morotti A, Casetta I, Fainardi E, Huynh T, Elkabouli M, Talbot Z, Melkus G, Aviv RI. Clinical features, non-contrast CT radiomic and radiological signs in models for the prediction of hematoma expansion in intracerebral hemorrhage. Can Assoc Radiol J 2023 Apr 18 [Online ahead of print].
18) Bala F, Kim BJ, Najm M, Thornton J, Fainardi E, Michel P, Alpay K, Herlihy D, Goyal M, Casetta I, Nannoni S, Ylikotila P, Power S, Saia V, Hegarty A, Pracucci G, Rautio R, Ademola A, Demchuk A, Mangiafico S, Boyle K, Hill MD, Toni D, Murphy S, Menon BK, Almekhlafi MA; Selection of Late-window Stroke for Thrombectomy by Imaging Collateral Extent (SOLSTICE) Consortium. Outcomes with endovascular treatment of patients with M2 Segment MCA occlusion in the late time window. AJNR Am J Neuroradiol 2023; 44: 447-452.
19) Naldi A, Pracucci G, Cavallo R, Saia V, Boghi A, Lochner P, Casetta I, Sallustio F, Zini A, Fainardi E, Cappellari M, Tassi R, Bracco S, Bigliardi G, Vallone S, Nencini P, Bergui M, Mangiafico S, Toni D; Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS) Investigators. Mechanical thrombectomy for in-hospital stroke: data from the Italian Registry of Endovascular Treatment in Acute Stroke. J Neurointerv Surg 2023 Mar 7 [Online ahead of print].
20) Toffali M, Carbone F, Fainardi E, Morotti A, Montecucco F, Liberale L, Padovani A. Secondary Prevention after Intracerebral Hemorrhage. Eur J Clin Invest 2023; 53: e13962.
21) Muscas G, Pisano A, Carrai R, Bianchi A, Capelli F, Montemurro VM, Martinelli C, Fainardi E, Grippo A, Della Puppa A. A diffusion tensor imaging-based prognostic classification for surgery of intrinsic lesions involving the motor pathways. World Neurosurg 2023; 172: e565-e573.
22) Salvadori E, Barucci E, Barbato C, Formelli B, Cesari F, Chiti S, Diciotti S, Giusti B, Gori AM, Marzi C, Pescini F, Pracucci G, Fainardi E, Marcucci R, Poggesi A. Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation. Strat-AF Study. Eur J Neurol 2023 30: 849-860.
23) Imreh S, Gadda D, Pandolfo C, Pellicanò G, Fainardi E. Post‑Traumatic haemorrhagic Tarlov’s cyst: a case report and review of literature. SN Compr Clin Med 2023; 5: 55.
24) Picetti E, Catena F, Abu-Zidan F, Ansaloni L, Armonda RA, Bala M, Balogh ZJ, Bertuccio A, Biffl WL, Bouzat P, Buki A, Cerasti D, Chesnut RM, Citerio G, Coccolini F, Coimbra R, Coniglio C, Fainardi E, Gupta D, Gurney JM, Hawrylux GWJ, Helbok R, Hutchinson PJA, Iaccarino C, Kolias A, Maier RW, Martin MJ, Meyfroidt G, Okonkwo DO, Rasulo F, Rizoli S, Rubiano A, Sahuquillo J, Sams VG, Servadei F, Sharma D, Shutter L, Stahel PF, Taccone FS, Udy A, Zoerle T, Agnoletti V, Bravi F, De Simone B, Kluger Y, Martino C, Moore EE, Sartelli M, Weber D, Robba C. Early management of isolated severe traumatic brain injury patients in a hospital without neurosurgical capabilities: a consensus and clinical recommendations of the World Society of Emergency Surgery (WSES). World J Emerg Surg 2023; 18: 5.
25) Morotti A, Boulouis G, Nawabi J, Li Q, Charidimou A, Pasi M, Schlunk F, Shoamanesh A, Katsanos AH, Mazzacane F, Busto G, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Warren AD, Laudisi M, Cavallini A, Gurol EM, Viswanathan A, Zini A, Casetta I, Fainardi E, Greenberg SM, Padovani A, Rosand J, Goldstein JN. Using noncontrast computed tomography to improve prediction of intracerebral hemorrhage expansion. Stroke 2023; 54: 567-574.
26) Morotti A, Li Q, Mazzoleni V, Nawabi J, Schlunk F, Mazzacane F, Busto G, Scola E, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Cavallini A, Zini A, Casetta I, Fainardi E, Dowlatshahi D, Padovani A, Arba F. Non-contrast CT markers of intracerebral hemorrhage expansion: the influence of onset-to-CT time. Int J Stroke 2023; 18: 704-711.
27)Morotti A, Nawabi J, Schlunk F, Poli L, Costa P, Mazzacane F, Busto G, Scola E, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Cavallini A, Gamba M, Magoni M, Gasparotti R, Padovani A, Pezzini A, Zini A, Fainardi E, Casetta I. Characteristics of early presenters after intracerebral hemorrhage. J Stroke 2022; 24: 425-428.
28) Muscas G, Orlandini S, Bonaudo C, Dardo M, Esposito A, Campagnaro L, Carrai R, Fainardi E, Ciccarino P, Della Puppa A. Functional outcomes, extent of resection, and bright/vague fluorescence interface in resection of glioblastomas involving the motor pathways assisted by 5-ALA. Acta Neurochir 2022; 164: 3267-3274.
29)Sallustio F, Pracucci G, Cappellari M, Saia V, Mascolo AP, Marrama F, Gandini R, Koch G, Diomedi M, D'Agostino F, Rocco A, Da Ros V, Wlderk A, Nezzo M, Argirò R, Morosetti D, Renieri L, Nencini P, Vallone S, Zini A, Bigliardi G, Pitrone A, Grillo F, Bracco S, Tassi R, Bergui M, Naldi A, Carità G, Casetta I, Gasparotti R, Magoni M, Simonetti L, Haznedari N, Paolucci M, Mavilio N, Malfatto L, Menozzi R, Genovese A, Cosottini M, Orlandi G, Comai A, Franchini E, Pedicelli A, Frisullo G, Puglielli E, Casalena A, Cester G, Baracchini C, Castellano D, Di Liberto A, Ricciardi GK, Chiumarulo L, Petruzzellis M, Lafe E, Persico A, Cavasin N, Critelli A, Semeraro V, Tinelli A, Giorgianni A, Carimati F, Auteri W, Rizzuto S, Biraschi F, Nicolini E, Ferrari A, Melis M, Calia S, Tassinari T, Nuzzi NP, Corato M, Sacco S, Squassina G, Invernizzi P, Gallesio I, Ruiz L, Dui G, Carboni N, Amistà P, Russo M, Maiore M, Zanda B, Craparo G, Mannino M, Inzitari D, Toni D, Mangiafico S; Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS) Collaborators. Carotid artery stenting during endovascular thrombectomy for acute ischemic stroke with tandem occlusion: the Italian Registry of Endovascular Treatment in Acute Stroke. Acta Neurol Belg 2022;123: 475-485.
30) Morotti A, Busto G, Boulouis G, Scola E, Padovani A, Casetta I, Fainardi E. Added value of non-contrast CT and CT perfusion markers for prediction of intracerebral hemorrhage expansion and outcome. Eur Radiol 2023; 33: 690-698.
31) Amoriello R, Rizzo R, Mariottini A, Bortolotti D, Gentili V, Bonechi E, Aldinucci A, Carnasciali A, Peruzzi B, Repice AM, Massacesi L, Fainardi E, Ballerini C. Investigating serum sHLA-G cooperation with MRI activity and disease-modifying treatment outcome in relapsing-remitting multiple sclerosis. Front Neurol 2022; 13: 872396.
32)Casetta I, Fainardi E, Pracucci G, Saia V, Sallustio F, da Ros V, Nappini S, Nencini P, Bigliardi G, Vinci S, Grillo F, Bracco S, Tassi R, Bergui M, Cerrato P, Saletti A, De Vito A, Gasparotti R, Magoni M, Simonetti L, Zini A, Ruggiero M, Longoni M, Castellan L, Malfatto L, Castellini P, Cosottini M, Comai A, Franchini E, Lozupone E, Della Marca G, Puglielli E, Casalena A, Baracchini C, Savio D, Duc E, Ricciardi G, Cappellari M, Chiumarulo L, Petruzzellis M, Cavallini A, Cavasin N, Critelli A, Burdi N, Boero G, Giorgianni A, Versino M, Biraschi F, Nicolini E, Comelli S, Melis M, Padolecchia R, Tassinari T, Paolo Nuzzi N, Marcheselli S, Sacco S, Invernizzi P, Gallesio I, Ferrandi D, Fancello M, Valeria Saddi M, Russo M, Pischedda A, Baule A, Mannino M, Florio F, Inchingolo V, Elena Flacco M, Romano D, Silvagni U, Inzitari D, Mangiafico S, Toni D; Italian Registry of Endovascular Thrombectomy in Acute Stroke (IRETAS). Sex differences in outcome after thrombectomy for acute ischemic stroke. A propensity score-matched study.Eur Stroke J 2022; 7: 151-157.
33) Bianconi E, Del Freo G, Salvadori E, Barbato C, Formelli B, Pescini F, Pracucci G, Sarti C, Cesari F, Chiti S, Diciotti S, Gori AM, Marzi C, Fainardi E, Giusti B, Marcucci R, Bertaccini B, Poggesi A. Can CHA 2 DS 2-VASc and HAS-BLED foresee the presence of cerebral microbleeds, lacunar and non-lacunar infarcts in elderly patients with atrial fibrillation? Data from Strat-AF Study.Front Neurol 2022; 13: 883786.
34) Scola E, Desideri I, Bianchi A, Gadda D, Busto G, Fiorenza A, Amadori T, Mancini S, Miele V, Fainardi E. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study. Radiol Med 2022; 127: 664-672.
35)Cappellari M, Saia V, Pracucci G, Fainardi E, Nencini P, Malfatto L, Tassi R, Cerrato P, Mancuso M, Pesare A, La Spina P, Lotti EM, Casalena A, Petruzzellis M, Baracchini C, Via AG, Gaudiano C, Sallustio F, Tassinari T, Critelli A, Melis M, Persico A, Casetta I, Sacco S, Ferrandi D, Marcheselli S, Russo M, Zivelonghi C, Mandruzzato N, Invernizzi P, Romano D, Nicolini E, Scoditti U, Magoni M, Cariddi LP, Vallone S, Inzitari D, Toni D, Mangiafico S; IRETAS group. Association of the careggi collateral score with radiological outcomes after thrombectomy for stroke with an occlusion of the middle cerebral artery. J Thromb Thrombolysis 2022; 54: 309-317.
36)Bortolotti D, Gentili V, Bortoluzzi A, Govoni M, Schiuma G, Beltrami S, Rizzo S, Baldi E, Caselli E, Pugliatti M, Castellazzi M, Fernández M, Fainardi E, Rizzo R. Herpesvirus infections in KIR2DL2-positive multiple sclerosis patients: mechanisms triggering autoimmunity. Microorganisms. 2022; 10: 494.
37) Morotti A, Boulouis G, Charidimou A, Poli L, Costa P, Giuli V, Leuci E, Mazzacane F, Busto G, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Cavallini A, Gamba M, Magoni M, Cornali C, Fontanella MM, Warren AD, Gurol EM, Viswanathan A, Gasparotti R, Casetta I, Fainardi E, Zini A, Pezzini A, Padovani A, Greenberg SM, Rosand J, Goldstein JN. Imaging markers of intracerebral hemorrhage expansion in patients with unclear symptom onset Int J Stroke. 2022; 17: 1013-1020.
38) Fainardi E, Busto G, Rosi A, Scola E, Casetta I, Bernardoni A, Saletti A, Arba F, Nencini P, Limbucci N, Mangiafico S, Demchuk A, Almekhlafi MA, Goyal M, Lee TY, Menon BK, Morotti A. Tmax volumes predict final infarct size and functional outcome in ischemic stroke patients receiving endovascular treatment. Ann Neurol 2022; 91: 878-888.
39)Azzolini F, Farina A, Gastaldi M, Barilaro A, Scotti V, Falchetti G, Fainardi E, Moretti M, Massacesi L. Leptomeningeal gadolinium enhancement in autoimmune GFAP astrocytopathy. Neurology 2022; 98: 720-722.
40) Mazzacane F, Mazzoleni V, Scola E, Mancini S, Lombardo I, Busto G, Rognone E, Pichiecchio A, Padovani A, Morotti A, Fainardi E. Vessel Wall Magnetic Resonance Imaging in Cerebrovascular Diseases. Diagnostics 2022; 12: 258
41) Almekhlafi MA, Thornton J, Casetta I, Goyal M, Nannoni S, Herlihy D, Fainardi E, Power S, Saia V, Hegarty A, Pracucci G, Demchuk A, Mangiafico S, Boyle K, Michel P, Bala F, Gill R, Kuczynski A, Ademola A, Hill MD, Toni D, Murphy S, Kim BJ, Menon BK; Selection Of Late-window Stroke for Thrombectomy by Imaging Collateral Extent (SOLSTICE) Consortium. Stroke imaging prior to thrombectomy in the late window results from a pooled multicentre analysis. J Neurol Neurosurg Psychiatry 2022 93: 468-474.
42) Silvagni E, Bortoluzzi A, Borrelli M, Bianchi A, Fainardi E, Govoni M. Cerebral microstructure analysis by diffusion-based MRI in systemic lupus erythematosus: lessons learned and research directions. Brain Sci. 2021; 12: 70.
43)Morotti A, Pilotto A, Mazzoleni V, Fainardi E, Casetta I, Cavallini A, Del Moro G, Candeloro E, Janes F, Costa P, Zini A, Leuci E, Mazzacane F, Magno S, Rustemi O, Raneri F, Canova G, Valente M, Giorgianni A, Solazzo F, Versino M, Mauri M, Gentile M, Migliaccio L, Forlivesi S, Magni E, Del Zotto E, Benussi A, Premi E, Gamba M, Poli L, Pezzini A, Gasparotti R, Magoni M, Gipponi S, Padovani A. Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19. Neuroradiology 2022; 4: 1367-1372.
44) Bala F, Casetta I, Nannoni S, Herlihy D, Goyal M, Fainardi E, Michel P, Thornton J, Power S, Saia V, Hegarty A, Pracucci G, Demchuk A, Mangiafico S, Boyle K, Hill MD, Toni D, Murphy S, Ademola A, Kim BJ, Menon BK, Almekhlafi MA. Sex-related differences in outcomes after endovascular treatment of patients with late-window stroke. Stroke 2022; 53: 311-318.
45)Cappellari M, Saia V, Pracucci G, Fainardi E, Consoli A, Nappini S, Castellan L, Bracco S, Bergui M, Cosottini M, Vangosa AB, Vinci S, Ruggiero M, Puglielli E, Chiumarulo L, Cester G, Comelli C, Silvagni U, Morosetti D, Caldiera V, Cavasin N, Ledda V, Sanfilippo G, Saletti A, Filauri P, Gallesio I, Nuzzi NP, Amistá P, Zivelonghi C, Plebani M, Pavia M, Romano D, Biraschi F, Menozzi R, Gasparotti R, Giorgianni A, Zini A, Inzitari D, Toni D, Mangiafico S; IRETAS Group. Association of the careggi collateral score with 3-month modified rankin scale score after thrombectomy for stroke with occlusion of the middle cerebral artery. J Neurol 2022 269:1024-1025.
46) Arba F, Rinaldi C, Boulouis G, Fainardi E, Charidimou A, Morotti A. Noncontrast computed tomography markers of cerebral hemorrhage expansion: Diagnostic Accuracy Meta-Analysis. Int J Stroke 2022; 17: 835-847.
47) Conti E, Piccardi B, Sodero A, Tudisco L, Lombardo I, Fainardi E, Nencini P, Sarti C, Allegra Mascaro AL, Baldereschi M. Translational stroke research review: using the mouse to model human futile recanalization and reperfusion injury in ischemic brain tissue. Cells 2021; 10: 3308.
48) Rostagno C, Maiani S, Di Donato R, Bandini G, Grassi E, Fainardi E. Severe neurologic impairment and respiratory failure after fall and hip fracture in an elderly woman. Clin Case Rep 2021; 9: e05145.
49) Bianchi A, Coviello C, Leonardi V, Luzzati M, Chiti S, Ermini D, Miele V, Fainardi E, Dani C, Scola E. In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report. Ital J Pediatr 2021; 47: 227.
50) Casetta I, Fainardi E, Pracucci G, Saia V, Vallone S, Zini A, Bergui M, Cerrato P, Nappini S, Nencini P, Gasparotti R, Saletti A, Causin F, Romano D, Burdi N, Giorgianni A, Mangiafico S, Toni D. Endovascular treatment beyond 24 hours from the onset of acute ischemic stroke: the Italian Registry of Endovascular Thrombectomy in Acute Stroke (IRETAS). J Neurointerv Surg 2022; 14: 1186-1188.
51) Filippi M, Preziosa P, Meani A, Costa GD, Mesaros S, Drulovic J, Ivanovic J, Rovira A, Tintorè M, Montalban X, Ciccarelli O, Brownlee W, Miszkiel K, Enzinger C, Khalil M, Barkhof F, Strijbis EMM, Frederiksen JL, Cramer SP, Fainardi E, Amato MP, Gasperini C, Ruggieri S, Martinelli V, Comi G, Rocca MA; MAGNIMS Study Group. Performance of the 2017 and 2010 revised McDonald Criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study. Neurology 2022; 98: e1-e14.
52) Morotti A, Busto G, Boulouis G, Scola E, Bernardoni A, Fiorenza A, Amadori T, Carbone F, Casetta I, Montecucco F, Fainardi E. Delayed perihematomal hypoperfusion is associated with poor outcome in intracerebral hemorrhage. Eur J Clin Invest 2022; 52: e13696.
53) Singh N, Bala F, Kim BJ, Najm M, Ahn SH, Fainardi E, Rubiera M, Khaw AV, Zini A, Goyal M, Menon BK, Almekhlafi M. Time-resolved assessment of cortical venous drainage on multiphase CT angiography in patients with acute ischemic stroke. Neuroradiology 2022; 64: 897-903.
54) Ospel JM, Volny O, Qiu W, Najm M, Hafeez M, Abdalrahman S, Fainardi E, Rubiera M, Khaw A, Shankar JJ, Hill MD, Almekhlafi MA, Demchuk AM, Goyal M, Menon BK. Impact of multiphase computed tomography angiography for endovascular treatment decision-making on outcomes in patients with acute ischemic stroke. J Stroke 2021; 23: 377-387.
55) Petrella L, Muscas G, Montemurro VM, Lastrucci G, Fainardi E, Pansini G, Della Puppa A. Use of the Subdural Hematoma in the Elderly (SHE) score to predict 30-day mortality after chronic subdural hematoma evacuation. World Neurosurg 2022; 157: e294-e300.
56) Graham NSN, Zimmerman KA, Moro F, Heslegrave A, Maillard SA, Bernini A, Miroz JP, Donat CK, Lopez MY, Bourke N, Jolly AE, Mallas EJ, Soreq E, Wilson MH, Fatania G, Roi D, Patel MC, Garbero E, Nattino G, Baciu C, Fainardi E, Chieregato A, Gradisek P, Magnoni S, Oddo M, Zetterberg H, Bertolini G, Sharp DJ. Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Sci Transl Med 2021; 13: eabg9922.
57) Rebchuk AD, Field TS, Hill MD, Goyal M, Demchuk A, Holodinsky JK, Fainardi E, Shankar J, Najm M, Rubiera M, Khaw AV, Qiu W, Menon BK. Determinants of leptomeningeal collateral status variability in ischemic stroke patients. Can J Neurol Sci 2022; 49: 767-773.
58) Gradisek P, Carrara G, Antiga L, Bottazzi B, Chieregato A, Csomos A, Fainardi E, Filekovic S, Fleming J, Hadjisavvas A, Kaps R, Kyprianou T, Latini R, Lazar I, Masson S, Mikaszewska-Sokolewicz M, Novelli D, Paci G, Xirouchaki N, Zanier ER, Nattino G, Bertolini G. Prognostic value of a combination of circulating biomarkers in critically ill patients with traumatic brain injury: results from the European CREACTIVE study. J Neurotrauma. 2021; 38: 2667-2676.
59) Arba F, Piccardi B, Palumbo V, Biagini S, Galmozzi F, Iovene V, Giannini A, Testa GD, Sodero A, Nesi M, Gadda D, Moretti M, Lamassa M, Pescini F, Poggesi A, Sarti C, Nannoni S, Pracucci G, Limbucci N, Nappini S, Renieri L, Grifoni S, Fainardi E, Inzitari D, Nencini P. Blood-brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study. Eur J Neurol 2021; 28: 3147-3154.
60)Castellazzi M, Ferri C, Alfiero S, Lombardo I, Laudisi M, Tecilla G, Boni M, Pizzicotti S, Fainardi E, Bellini T, Pugliatti M. Sex-related differences in cerebrospinal fluid plasma-derived proteins of neurological patients. Diagnostics 2021; 11: 884.
61) Morotti A, Busto G, Scola E, Carlesi E, Di Pasquale F, Casetta I, Fainardi E. Association between perihematomal perfusion and intracerebral hemorrhage shape. Neuroradiology 2021; 63: 1563-1567.
62) Sporns PB, Psychogios MN, Boulouis G, Charidimou A, Li Q, Fainardi E, Dowlatshahi D, Goldstein JN, Morotti A. Neuroimaging of Acute Intracerebral Hemorrhage. J Clin Med 2021; 10: 1086.
63) Morotti A, Boulouis G, Charidimou A, Li Q, Poli L, Costa P, De Giuli V, Leuci E, Mazzacane F, Busto G, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Micieli G, Cavallini A, Candeloro E, Gamba M, Magoni M, Warren AD, Anderson CD, Gurol ME, Biffi A, Viswanathan A, Casetta I, Fainardi E, Zini A, Pezzini A, Padovani A, Greenberg SM, Rosand J, Goldstein JN. Hematoma expansion in intracerebral hemorrhage with unclear onset. Neurology 2021; 96: e2363-e2371.
64) Arba F, Rinaldi C, Caimano D, Vit F, Busto G, Fainardi E. Blood-brain barrier disruption and hemorrhagic transformation in acute ischemic stroke: systematic review and meta-analysis. Front Neurol. 2021; 11: 594613.
65) Silvagni E, Inglese F, Bortoluzzi A, Borrelli M, Goeman JJ, Revenaz A, Groppo E, Steup-Beekman GM, Huizinga TWJ, Ronen I, de Bresser J, Fainardi E, Govoni M, Ercan E. Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients. Rheumatology 2021; 60: 2678-2687.
66)Cagnazzo F, Piotin M, Escalard S, Maier B, Ribo M, Requena M, Pop R, Hasiu A, Gasparotti R, Mardighian D, Piano M, Cervo A, Eker OF, Durous V, Sourour NA, Elhorany M, Zini A, Simonetti L, Marcheselli S, Paolo NN, Houdart E, Guédon A, Ligot N, Mine B, Consoli A, Lapergue B, Cordona Portela P, Urra X, Rodriguez A, Bolognini F, Lebedinsky PA, Pasco-Papon A, Godard S, Marnat G, Sibon I, Limbucci N, Nencini P, Nappini S, Saia V, Caldiera V, Romano D, Frauenfelder G, Gallesio I, Gola G, Menozzi R, Genovese A, Terrana A, Giorgianni A, Cappellari M, Augelli R, Invernizzi P, Pavia M, Lafe E, Cavallini A, Giossi A, Besana M, Valvassori L, Macera A, Castellan L, Salsano G, Di Caterino F, Biondi A, Arquizan C, Lebreuche J, Galvano G, Cannella A, Cosottini M, Lazzarotti G, Guizzardi G, Stecco A, Tassi R, Bracco S, Bianchini E, Micieli C, Pascarella R, Napoli M, Causin F, Desal H, Cotton F, Costalat V; ET-COVID-19 Study Group. European multicenter study of ET-COVID-19. Stroke 2021; 52: 31-39.
67) Kuang H, Qiu W, Boers AM, Brown S, Muir K, Majoie CBLM, Dippel DWJ, White P, Epstein J, Mitchell PJ, Dávalos A, Bracard S, Campbell B, Saver JL, Jovin TG, Rubiera M, Khaw AV, Shankar JJ, Fainardi E, Hill MD, Demchuk AM, Goyal M, Menon BK; PRoveIT and HERMES Collaborators. Computed tomography perfusion-based machine learning model better predicts follow-up infarction in patients with acute ischemic stroke. Stroke 2021; 52: 223-231.
68)Salvadori E, Galmozzi F, Uda F, Barbato C, Camilleri E, Cesari F, Chiti S, Diciotti S, Donnini S, Formelli B, Galora S, Giusti B, Gori AM, Marzi C, Melone A, Mistri D, Pescini F, Pracucci G, Rinnoci V, Sarti C, Fainardi E, Marcucci R, Poggesi A. Association between motor and cognitive performances in Elderly With Atrial Fibrillation: Strat-AF Study. Front Neurol. 2020; 11: 571978.
69) Bianchi A, Mazzoni LN, Busoni S, Pinna N, Albanesi M, Cavigli E, Cozzi D, Poggesi A, Miele V, Fainardi E, Gadda D. Assessment of cerebrovascular disease with computed tomography in COVID-19 patients: correlation of a novel specific visual score with increased mortality risk. Radiol Med 2021;126: 570-576.
70) Graham NSN, Zimmerman KA, Bertolini G, Magnoni S, Oddo M, Zetterberg H, Moro F, Novelli D, Heslegrave A, Chieregato A, Fainardi E, Fleming JM, Garbero E, Abed-Maillard S, Gradisek P, Bernini A, Sharp DJ. Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol. BMJ Open 2020; 10: e042093
71) Ospel JM, Menon BK, Demchuk AM, Almekhlafi MA, Kashani N, Mayank A, Fainardi E, Rubiera M, Khaw A, Shankar JJ, Dowlatshahi D, Puig J, Sohn SI, Ahn SH, Poppe A, Calleja A, Hill MD, Goyal M. Clinical course of acute ischemic stroke due to medium vessel occlusion with and without intravenous alteplase treatment. Stroke 2020; 51: 3232-3240.
72) Volny O, Zerna C, Tomek A, Bar M, Rocek M, Padr R, Cihlar F, Nevsimalova M, Jurak L, Havlicek R, Kovar M, Sevcik P, Rohan V, Fiksa J, Cernik D, Jura R, Vaclavik D, Cimflova P, Puig J, Dowlatshahi D, Khaw AV, Fainardi E, Najm M, Demchuk AM, Menon BK, Mikulik R, Hill MD. Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke. Neurology 2020; 95: e3364-e3372
73) Morotti A, Fainardi E. Response by Morotti and Fainardi to letter regarding article, "Subarachnoid extension predicts lobar intracerebral hemorrhage expansion". Stroke 2020; 51: e162.
74)Castellazzi M, Pizzicotti S, Lombardo I, Alfiero S, Morotti A, Pellegatti P, Negri G, Natali L, Ferri C, Fainardi E, Bellini T, Pugliatti M. Sexual dimorphism in the cerebrospinal fluid total protein content. Clin Chem Lab Med 2020; 58: 1885-1890.
75) Casetta I, Fainardi E, Saia V, Pracucci G, Padroni M, Renieri L, Nencini P, Inzitari D, Morosetti D, Sallustio F, Vallone S, Bigliardi G, Zini A, Longo M, Francalanza I, Bracco S, Vallone IM, Tassi R, Bergui M, Naldi A, Saletti A, De Vito A, Gasparotti R, Magoni M, Castellan L, Serrati C, Menozzi R, Scoditti U, Causin F, Pieroni A, Puglielli E, Casalena A, Sanna A, Ruggiero M, Cordici F, Di Maggio L, Duc E, Cosottini M, Giannini N, Sanfilippo G, Zappoli F, Cavallini A, Cavasin N, Critelli A, Ciceri E, Plebani M, Cappellari M, Chiumarulo L, Petruzzellis M, Terrana A, Cariddi LP, Burdi N, Tinelli A, Auteri W, Silvagni U, Biraschi F, Nicolini E, Padolecchia R, Tassinari T, Filauri P, Sacco S, Pavia M, Invernizzi P, Nuzzi NP, Marcheselli S, Amistà P, Russo M, Gallesio I, Craparo G, Mannino M, Mangiafico S, Toni D; Italian Registry of Endovascular Treatment in Acute Stroke. Endovascular thrombectomy for acute ischemic stroke beyond 6 hours from onset: A real-world experience. Stroke 2020; 51: 2051-2057.
76)Morotti A, Poli L, Leuci E, Mazzacane F, Costa P, De Giuli V, Candeloro E, Busto G, Casetta I, Micieli G, Cavallini A, Gamba M, Magoni M, Padovani A, Pezzini A, Fainardi E. Subarachnoid Extension Predicts Lobar Intracerebral Hemorrhage Expansion. Stroke 2020; 51: 1470-1476.
77) Fonderico M, Biagioli T, Lanzilao L, Bellinvia A, Fratangelo R, Pastò L, Prestipino E, Razzolini L, Tudisco L, Ginestroni A, Vuolo L, Fainardi E, Ballerini C, Portaccio E, Amato MP Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series. Mult Scler 2021; 27: 198-207.
78) Morotti A, Busto G, Bernardoni A, Marini S, Casetta I, Fainardi E. Association between perihematomal perfusion and intracerebral hemorrhage outcome. Neurocrit Care 2020; 33: 525-532.
79) Castellazzi M, Morotti A, Tamborino C, Alessi F, Pilotto S, Baldi E, Caniatti LM, Trentini A, Casetta I, Granieri E, Pugliatti M, Fainardi E, Bellini T. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient. Fluids Barriers CNS 2020; 2020; 17: 14.
80) Morotti A, Busto G, Bernardoni A, Leuci E, Casetta I, Fainardi E. Comparison of perihematomal perfusion in deep and lobar intracerebral hemorrhage. Neuroradiology 2020; 62: 257-261.
81) Almekhlafi MA, Kunz WG, McTaggart RA, Jayaraman MV, Najm M, Ahn SH, Fainardi E, Rubiera M, Khaw AV, Zini A, Hill MD, Demchuk AM, Goyal M, Menon BK. Imaging triage of patients with late-window (6-24 Hours) acute ischemic stroke: a comparative study using multiphase CT angiography versus CT perfusion. AJNR Am J Neuroradiol 2020; 41: 129-133.
82) Fainardi E, Bortolotti D, Castellazzi M, Casetta I, Bellini T, Rizzo R. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study. Hum Immunol 2020; 81: 156-161.
83)Giuli VD, Besana M, Grassi M, Zedde M, Zini A, Lodigiani C, Marcheselli S, Cavallini A, Micieli G, Rasura M, DeLodovici ML, Tomelleri G, Checcarelli N, Chiti A, Giorli E, Sette MD, Tancredi L, Toriello A, Braga M, Morotti A, Poli L, Caria F, Gamba M, Patella R, Spalloni A, Simone AM, Pascarella R, Beretta S, Fainardi E, Padovani A, Gasparotti R, Pezzini A; Italian Project on Stroke in Young Adults (IPSYS) Investigators. History of Migraine and Volume of Brain Infarcts: The Italian Project on Stroke at Young Age (IPSYS). J Stroke 2019; 3: 324-331.
84) Poggesi A, Barbato C, Galmozzi F, Camilleri E, Cesari F, Chiti S, Diciotti S, Galora S, Giusti B, Gori AM, Marzi C, Melone A, Mistri D, Pescini F, Pracucci G, Rinnoci V, Sarti C, Fainardi E, Marcucci R, Salvadori E. Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF Study): Study Design and Methodology. Medicina 2019; 55: 10.
85) Arba F, Giannini A, Piccardi B, Biagini S, Palumbo V, Giusti B, Nencini P, Gori AM, Mascia Nesi M, Pracucci G, Bono G, Bovi P, Fainardi E, Consoli D, Nucera A, Massaro F, Orlandi G, Perini P, Tassi R, Sessa M, Toni D, Abbate R, Inzitari D; on behalf of the Magic Study Group. Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke. Eur J Stroke 2019; 4: 119-126.
86) Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Fainardi E, Casetta I, Granieri E, Pugliatti M, Pinton P. Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients. J Neuroinflammation 2019; 16: 131.
87)Cappellari M, Mangiafico S, Saia V, Pracucci G, Nappini S, Nencini P, Konda D, Sallustio F, Vallone S, Zini A, Bracco S, Tassi R, Bergui M, Cerrato P, Pitrone A, Grillo F, Saletti A, De Vito A, Gasparotti R, Magoni M, Puglielli E, Casalena A, Causin F, Baracchini C, Castellan L, Malfatto L, Menozzi R, Scoditti U, Comelli C, Duc E, Comai A, Franchini E, Cosottini M, Mancuso M, Peschillo S, De Michele M, Giorgianni A, Delodovici ML, Lafe E, Denaro MF, Burdi N, Internò S, Cavasin N, Critelli A, Chiumarulo L, Petruzzellis M, Doddi M, Carolei A, Auteri W, Petrone A, Padolecchia R, Tassinari T, Pavia M, Invernizzi P, Turcato G, Forlivesi S, Ciceri EFM, Bonetti B, Inzitari D, Toni D; Listing of IER Collaborators. IER-SICH nomogram to predict symptomatic intracerebral hemorrhage after thrombectomy for stroke. Stroke 2019; 50: 909-916.
88) Morotti A, Busto G, Bernardoni A, Tamborino C, Fainardi E. Association between perihematomal cerebral blood volume and intracerebral hemorrhage expansion: A computed tomography perfusion study. Ann Neurol 2019; 85: 943-947.
89)Fierini F, Poggesi A, Salvadori E, Acquafresca M, Fainardi E, Moretti M, Pantoni L. Cerebral small vessel disease and systemic arteriopathy in intracranial arterial dolichoectasia patients. Acta Neurol Scand 2019 139:150-157.
90) Spalletti M, Orzalesi V, Carrai R, Bucciardini L, Cossu C, Scarpino M, Fainardi E, Marinoni M, Grippo A, Amantini A. Amplitude instability of somatosensory evoked potentials as an indicator of delayed cerebral ischemia in a case of subarachnoid hemorrhage. Clin EEG Neurosci 2019; 50: 205-209.
91) Carbone F, Busto G, Padroni M, Bernardoni A, Colagrande S, Dallegri F, Montecucco F, Fainardi E. Radiologic Cerebral reperfusion at 24 h predicts good clinical outcome. Transl Stroke Res 2019; 10: 178-188.
92) Arba F, Piccardi B, Palumbo V, Giusti B, Nencini P, Gori AM, Sereni A, Nesi M, Pracucci G, Bono G, Bovi P, Fainardi E, Consoli D, Nucera A, Massaro F, Orlandi G, Perini F, Tassi R, Sessa M, Toni D, Abbate R, Inzitari D; MAGIC Study Group. Small vessel disease is associated with tissue inhibitor of matrix metalloproteinase-4 after ischaemic stroke. Transl Stroke Res 2019; 10: 44-51.
93) Castellazzi M, Ligi D, Contaldi E, Quartana D, Fonderico M, Borgatti L, Bellini T, Trentini A, Granieri E, Fainardi E, Mannello F, Pugliatti M. Multiplex matrix metalloproteinases analysis in the cerebrospinal fluid reveals potential specific patterns in multiple sclerosis patients. Front Neurol 2018; 9: 1080.
94) Piccardi B, Arba F, Nesi M, Palumbo V, Nencini P, Giusti B, Sereni A, Gadda D, Moretti M, Fainardi E, Mangiafico S, Pracucci G, Nannoni S, Galmozzi F, Fanelli A, Pezzati P, Vanni S, Grifoni S, Sarti C, Lamassa M, Poggesi A, Pescini F, Pantoni L, Gori AM, Inzitari D. Reperfusion Injury after ischemic Stroke Study (RISKS): single-centre (Florence, Italy), prospective observational protocol study. BMJ Open 2018; 8: e021183.
95) Pezzini A, Busto G, Zedde M, Gamba M, Zini A, Poli L, Caria F, De Giuli V, Simone AM, Pascarella R, Padovani A, Padroni M, Gasparotti R, Colagrande S, Fainardi E. Vulnerability to infarction during cerebral ischemia in migraine sufferers. Stroke 2018; 49: 573-578.
96) Najm M, Al-Ajlan FS, Boesen ME, Hur L, Kim CK, Fainardi E, Hill MD, Demchuk AM, Goyal M, Lee TY, Menon BK. Defining CT Perfusion Thresholds for infarction in the golden hour and with ultra-early reperfusion. Can J Neurol Sci 2018; 45: 339-342.
97)Franceschi E, Tosoni A, Minichillo S, Depenni R, Paccapelo A, Bartolini S, Michiara M, Pavesi G, Urbini B, Crisi G, Cavallo MA, Tosatto L, Dazzi C, Biasini C, Pasini G, Balestrini D, Zanelli F, Ramponi V, Fioravanti A, Giombelli E, De Biase D, Baruzzi A, Brandes AA; PERNO Study Group. The Prognostic roles of gender and O6-Methylguanine-DNA methyltransferase methylation status in glioblastoma patients: The Female Power. World Neurosurg 2018;112: e342-e347.
98)Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, De Luca G, Cataldo I, Biagioli T, Ballerini C, Castellazzi M, Fainardi E, Pettini P, Zaffaroni M, Giunti D, Capello E, Bernardi G, Ciusani E, Giannotta C, Nobile-Orazio E, Bazzigaluppi E, Passerini G, Bedin R, Sola P, Brivio R, Cavaletti G, Sala A, Bertolotto A, Desina G, Leone MA, Mariotto S, Ferrari S, Paternoster A, Giavarina D, Lolli F, Franciotta D. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci 2017; 38 (Suppl 2): 217-224.
99) Santos EMM, d'Esterre CD, Treurniet KM, Niessen WJ, Najm M, Goyal M, Demchuk AM, Majoie CB, Menon BK, Marquering HA; PRove-IT investigators. Added value of multiphase CTA imaging for thrombus perviousness assessment. Neuroradiology 2018; 60: 71-79.
100) Lausch A, Yeung TP, Chen J, Law E, Wang Y, Urbini B, Donelli F, Manco L, Fainardi E, Lee TY, Wong E. A generalized parametric response mapping method for analysis of multi-parametric imaging: a feasibility study with application to glioblastoma. Med Phys 2017; 44: 6074-6084.
101) Liberale L, Montecucco F, Bonaventura A, Casetta I, Seraceni S, Trentini A, Padroni M, Dallegri F, Fainardi E, Carbone F. Monocyte count at onset predicts post-stroke outcomes during a 90-day follow up. Eur J Clin Invest 2017; 47: 702-710.
102) Castellazzi M, Pugliatti M, Granieri E, Fainardi E. A commentary on the use of Epstein-Barr virus specific antibodies as biological markers in multiple sclerosis. J Neurol Neurophysiol 2017, 8: 428.
103) Trentini A, Castellazzi M, Romani A, Squerzanti M, Baldi E, Caniatti ML, Pugliatti M, Granieri E, Fainardi E, Bellini T, Cervellati C. Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci 2017; 377: 133-136.
104) Batchelor C, Pordeli P, d'Esterre CD, Najm M, Al-Ajlan FS, Boesen ME, McDougall C, Hur L, Fainardi E, Shankar JJS, Rubiera M, Khaw AV, Hill MD, Demchuk AM, Sajobi TT, Goyal M, Lee TY, Aviv RI, Menon BK. Use of noncontrast computed tomography and computed tomographic perfusion in predicting intracerebral hemorrhage after intravenous alteplase therapy. Stroke 2017 48:1548-1553.
105) d'Esterre CD, Trivedi A, Pordeli P, Boesen M, Patil S, Hwan Ahn S, Najm M, Fainardi E, Shankar JJ, Rubiera M, Almekhlafi MA, Mandzia J, Khaw AV, Barber P, Coutts S, Hill MD, Demchuk AM, Sajobi T, Forkert ND, Goyal M, Lee TY, Menon BK. Regional comparison of multiphase computed tomographic angiography and computed tomographic perfusion for prediction of tissue fate in ischemic stroke. Stroke 2017; 48: 939-945.
106) Rizzo R, Fainardi E, Rouas-Freiss N, Morandi F. The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016. J Immunol Res 2017; 2017: 2309574.
107)Baldin E, Testoni S, de Pasqua S, Ferro S, Albani F, Baruzzi A, D'Alessandro R; PERNO study group. Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy. Neurol Sci 2017; 38: 255-262
108)Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G, Urbini B, Pisanello A, Crisi G, Cavallo MA, Dazzi C, Biasini C, Bertolini F, Mucciarini C, Pasini G, Baruzzi A, Brandes AA; PERNO Study Group. Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study. J Neurooncol 2016; 128: 157-162.
109) Liberale L, Montecucco F, Casetta I, Seraceni S, Trentini A, Padroni M, Dallegri F, Mach F, Fainardi E, Carbone F. Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes. Eur J Clin Invest 2016; 46: 1053-1062.
110) Rizzo R, Gabrielli L, Bortolotti D, Gentili V, Piccirilli G, Chiereghin A, Pavia C, Bolzani S, Guerra B, Simonazzi G, Cervi F, Capretti MG, Fainardi E, Luca DD, Landini MP, Lazzarotto T. Study of soluble HLA-G in congenital human cytomegalovirus infection. J Immunol Res 2016; 2016: 3890306.
111) Morandi F, Rizzo R, Fainardi E, Rouas-Freiss N, Pistoia V. Recent Advances in Our Understanding of HLA-G Biology: Lessons from a wide spectrum of human diseases. J Immunol Res 2016; 2016: 4326495.
112)Trentini A, Castellazzi M, Cervellati C, Manfrinato MC, Tamborino C, Hanau S, Volta CA, Baldi E, Kostic V, Drulovic J, Granieri E, Dallocchio F, Bellini T, Dujmovic I, Fainardi E. Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients. Dis Markers 2016; 2016: 3672353.
113) Carbone F, Satta N, Montecucco F, Virzi J, Burger F, Roth A, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A, Padroni M, Dallegri F, Lalive PH, Mach F, Fainardi E, Vuilleumier N. Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes. Eur J Clin Invest 2016; 46: 805-817.
114) Rizzo R, Pietrobon S, Mazzoni E, Bortolotti D, Martini F, Castellazzi M, Casetta I, Fainardi E, Di Luca D, Granieri E, Tognon M; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis. J Transl Med 2016; 14: 216.
115) Eilaghi A, Yeung T, d'Esterre C, Bauman G, Yartsev S, Easaw J, Fainardi E, Lee TY, Frayne R. Quantitative perfusion and permeability biomarkers in brain cancer from tomographic CT and MR images. Biomark Cancer 2016; 8 (Suppl 2): 47-59.
116)Castellazzi M, Bellini T, Trentini A, Delbue S, Elia F, Gastaldi M, Franciotta D, Bergamaschi R, Manfrinato MC, Volta CA, Granieri E, Fainardi E. Serum gelatinases levels in multiple sclerosis patients during 21 months of natalizumab therapy. Dis Markers 2016; 2016: 8434209.
117) Castellazzi M, Trentini A, Romani A, Valacchi G, Bellini T, Bonaccorsi G, Fainardi E, Cavicchio C, Passaro A, Zuliani G, Cervellati C. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases. Int J Biochem Cell Biol 2016; 81: 356-363.
118) Rizzo R, Bortolotti D, Fainardi E, Gentili V, Bolzani S, Baldi E, Casetta I, Granieri E, Rotola A, Furlan R, Di Luca D. KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients. J Neuroimmunol 2016; 294: 1-5.
119) Padroni M, Bernardoni A, Tamborino C, Roversi G, Borrelli M, Saletti A, De Vito A, Azzini C, Borgatti L, Marcello O, d'Esterre C, Ceruti S, Casetta I, Lee TY, Fainardi E. Cerebral blood volume ASPECTS is the best predictor of clinical outcome in acute ischemic stroke: A Retrospective, Combined Semi-Quantitative and Quantitative Assessment. PLoS One 2016; 11: e0147910.
120) Consoli A, Andersson T, Holmberg A, Verganti L, Saletti A, Vallone S, Zini A, Cerase A, Romano D, Bracco S, Lorenzano S, Fainardi E, Mangiafico S. CAPRI Collaborative Group. CT perfusion and angiographic assessment of pial collateral reperfusion in acute ischemic stroke: the CAPRI study. J Neurointerv Surg 2016; 8: 1211-1216.
121) Revenaz A, Ruggeri M, Laganà M, Bergsland N, Groppo E, Rovaris M, Fainardi E. A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures. BMC Med Imaging. 2016; 16: 4.
122)Azzini C, Gentile M, De Vito A, Traina L, Sette E, Fainardi E, Mascoli F, Casetta I. Very early carotid endarterectomy after intravenous thrombolysis. Eur J Vasc Endovasc Surg 2016; 51: 482-486.
123) d'Esterre CD, Boesen ME, Ahn SH, Pordeli P, Najm M, Minhas P, Davari P, Fainardi E, Rubiera M, Khaw AV, Zini A, Frayne R, Hill MD, Demchuk AM, Sajobi TT, Forkert ND, Goyal M, Lee TY, Menon BK. Time-dependent computed tomographic perfusion thresholds for patients with acute ischemic stroke. Stroke. 2015; 46: 3390-3397.
124) Garbarini F, Turella L, Rabuffetti M, Cantagallo A, Piedimonte A, Fainardi E, Berti A, Fadiga L. Bimanual non-congruent actions in motor neglect syndrome: a combined behavioral/fMRI study. Front Hum Neurosci 2015; 9: 541.
125) Yang J, d'Esterre C, Ceruti S, Roversi G, Saletti A, Fainardi E, Lee TY. Temporal changes in blood-brain barrier permeability and cerebral perfusion in lacunar/subcortical ischemic stroke. BMC Neurol 2015; 15: 214.
126)Carbone F, Burger F, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A, Padroni M, Bertolotto M, Dallegri F, Mach F, Fainardi E, Montecucco F. Leptin/adiponectin ratio predicts poststroke neurological outcome. Eur J Clin Invest 2015; 45: 1184-1191.
127) Castellazzi M, Delbue S, Elia F, Gastaldi M, Franciotta D, Rizzo R, Bellini T, Bergamaschi R, Granieri E, Fainardi E. Epstein-Barr virus specific antibody response in multiple sclerosis patients during 21 months of natalizumab treatment. Dis Markers. 2015; 2015: 901312.
128) Fainardi E, Bortolotti D, Bolzani S, Castellazzi M, Tamborino C, Roversi G, Baldi E, Caniatti ML, Casetta I, Gentili V, Granieri E, Rizzo R; ERMES study group. Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis. Mult Scler 2016; 22: 245-249.
129) d'Esterre CD, Roversi G, Padroni M, Bernardoni A, Tamborino C, De Vito A, Azzini C, Marcello O, Saletti A, Ceruti S, Lee TY, Fainardi E. CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke. Neurol Sci 2015; 36: 1777-1783.
130) Corazza A, Manco L, Sghedoni R, Iori M, Nitrosi A, Bertolini M, Turra A, Fainardi E, Giampieri E, Remondini D, Castellani G. Modeling glioblastoma response to radiotherapy by combining a two-compartment kinetic model and multiparametric NMR data. J Mech Med Biol 2015; 2: 1540017.
131) d'Esterre CD, Aviv RI, Morrison L, Fainardi E, Lee TY. Acute Multi-modal Neuroimaging in a Porcine model of endothelin-1-induced cerebral ischemia: Defining the acute infarct core. Transl Stroke Res. 2015; 6: 234-241.
132) Yeung TP, Wang Y, He W, Urbini B, Gafà R, Ulazzi L, Yartsev S, Bauman G, Lee TY, Fainardi E; Project of Emilia-Romagna Region on Neuro-Oncology (PERNO) Study Group. Survival prediction in high-grade gliomas using CT perfusion imaging. J Neurooncol 2015; 123: 93-102.
133) Carbone F, Vuilleumier N, Burger F, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A, Padroni M, Dallegri F, Mach F, Fainardi E, Montecucco F. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke. Eur J Clin Invest. 2015; 45: 579-586.
134) Yeung TP, Bauman G, Yartsev S, Fainardi E, Macdonald D, Lee TY. Dynamic perfusion CT in brain tumors. Eur J Radiol 2015; 84: 2386-2392.
135) Ahn SH, d'Esterre CD, Qazi EM, Najm M, Rubiera M, Fainardi E, Hill MD, Goyal M, Demchuk AM, Lee TY, Menon BK. Occult anterograde flow is an underrRecognized but crucial predictor of early recanalization with intravenous tissue-type plasminogen activator. Stroke 2015;46: 968-975.
136)Trentini A, Manfrinato MC, Castellazzi M, Tamborino C, Roversi G, Volta CA, Baldi E, Tola MR, Granieri E, Dallocchio F, Bellini T, Fainardi E; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group; Emilia-Romagna network for Multiple Sclerosis ERMES study group. TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis. Mult Scler 2015; 21: 1121-1130.
137) Carbone F, Vuilleumier N, Bertolotto M, Burger F, Galan K, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A, Dallegri F, da Silva AR, Pende A, Artom N, Mach F, Coen M, Fainardi E, Montecucco F. Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. Vascul Pharmacol 2015; 64: 16-27.
138) Contini C, Granieri E, Fainardi E, Stratton CW. Role of chlamydophila pneumoniae in the pathogenesis of chronic cerebrospinal venous insuffiency in patients with multiple sclerosis. J Mult Scler 2015; 2: 150.
139)Brandes AA, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, Faedi M, Pisanello A, Crisi G, Urbini B, Dazzi C, Cavanna L, Mucciarini C, Pasini G, Bartolini S, Marucci G, Morandi L, Zunarelli E, Cerasoli S, Gardini G, Lanza G, Silini EM, Cavuto S, Baruzzi A, Baruzzi A, Albani F, Calbucci F, D'Alessandro R, Michelucci R, Brandes A, Eusebi V, Ceruti S, Fainardi E, Tamarozzi R, Emiliani E, Cavallo M, Franceschi E, Tosoni A, Cavallo M, Fiorica F, Valentini A, Depenni R, Mucciarini C, Crisi G, Sasso E, Biasini C, Cavanna L, Guidetti D, Marcello N, Pisanello A, Cremonini AM, Guiducci G, de Pasqua S, Testoni S, Agati R, Ambrosetto G, Bacci A, Baldin E, Baldrati A, Barbieri E, Bartolini S, Bellavista E, Bisulli F, Bonora E, Bunkheila F, Carelli V, Crisci M, Dall'Occa P, de Biase D, Ferro S, Franceschi C, Frezza G, Grasso V, Leonardi M, Marucci G, Mazzocchi V, Morandi L, Mostacci B, Palandri G, Pasini E, Pastore Trossello M, Pession A, Ragazzi M, Riguzzi P, Rinaldi R, Rizzi S, Romeo G, Spagnolli F, Tinuper P, Trocino C, Cerasoli S, Dall'Agata M, Faedi M, Frattarelli M, Gentili G, Giovannini A, Iorio P, Pasquini U, Galletti G, Guidi C, Neri W, Patuelli A, Strumia S, Casmiro M, Gamboni A, Rasi F, Cruciani G, Cenni P, Dazzi C, Guidi A, Zumaglini F, Amadori A, Pasini G, Pasquinelli M, Pasquini E, Polselli A, Ravasio A, Viti B, Sintini M, Ariatti A, Bertolini F, Bigliardi G, Carpeggiani P, Cavalleri F, Meletti S, Nichelli P, Pettorelli E, Pinna G, Zunarelli E, Artioli F, Bernardini I, Costa M, Greco G, Guerzoni R, Stucchi C, Iaccarino C, Rizzi R, Zuccoli G, Api P, Cartei F, Fallica E, Granieri E, Latini F, Lelli G, Monetti C, Ramponi V, Saletti A, Schivalocchi R, Seraceni S, Tola MR, Urbini B, Giorgi C, Montanari E, Cerasti D, Crafa P, Dascola I, Florindo I, Mazza S, Servadei F, Silini E, Torelli P, Immovilli P, Morelli N, Vanzo C. Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? Neurooncol Pract 2014; 1: 166-171.
140) Rizzo R, Bortolotti D, Bolzani S, Fainardi E. HLA-G Molecules in Autoimmune Diseases and Infections. Front Immunol 2014; 5: 592.
141)Paciaroni M, Inzitari D, Agnelli G, Caso V, Balucani C, Grotta JC, Sarraj A, Sung-Il S, Chamorro A, Urra X, Leys D, Henon H, Cordonnier C, Dequatre N, Aguettaz P, Alberti A, Venti M, Acciarresi M, D'Amore C, Zini A, Vallone S, Dell'Acqua ML, Menetti F, Nencini P, Mangiafico S, Barlinn K, Kepplinger J, Bodechtel U, Gerber J, Bovi P, Cappellari M, Linfante I, Dabus G, Marcheselli S, Pezzini A, Padovani A, Alexandrov AV, Shahripour RB, Sessa M, Giacalone G, Silvestrelli G, Lanari A, Ciccone A, De Vito A, Azzini C, Saletti A, Fainardi E, Orlandi G, Chiti A, Gialdini G, Silvestrini M, Ferrarese C, Beretta S, Tassi R, Martini G, Tsivgoulis G, Vasdekis SN, Consoli D, Baldi A, D'Anna S, Luda E, Varbella F, Galletti G, Invernizzi P, Donati E, De Lodovici ML, Bono G, Corea F, Sette MD, Monaco S, Riva M, Tassinari T, Scoditti U, Toni D. Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study. J Neurol 2015; 262: 459-468.
142) Cervellati C, Romani A, Fainardi E, Trentini A, Squerzanti M, Baldi E, Caniatti ML, Granieri E, Bellini T, Castellazzi M. Serum ferroxidase activity in patients with multiple sclerosis: a pilot study. In Vivo 2014; 28: 1197-1200.
143) Castellazzi M, Contini C, Tamborino C, Fasolo F, Roversi G, Seraceni S, Rizzo R, Baldi E, Tola M, Bellini T, Granieri E, Fainardi E. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies. J Neuroinflammation 2014; 11: 188.
144) Mazzoni E, Pietrobon S, Masini I, Rotondo JC, Gentile M, Fainardi E, Casetta I, Castellazzi M, Granieri E, Caniati ML, Tola MR, Guerra G, Martini F, Tognon M. Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis. PLoS One 2014; 9: e110923.
145) Morandi F, Fainardi E, Rizzo R, Rouas-Freiss N. The role of HLA-class Ib molecules in immune-related diseases, tumors, and infections. J Immunol Res 2014; 2014: 231618.
146) Alegre E, Rizzo R, Bortolotti D, Fernandez-Landázuri S, Fainardi E, González A. Some basic aspects of HLA-G biology. J Immunol Res 2014; 2014: 657625.
147) Rizzo R, Malagutti N, Bortolotti D, Gentili V, Rotola A, Fainardi E, Pezzolo T, Aimoni C, Pelucchi S, Di Luca D, Pastore A. Infection and HLA-G molecules in nasal polyposis. J Immunol Res 2014; 2014: 407430.
148)Trentini A, Bellini T, Manfrinato MC, Dallocchio F, Fainardi E, Alvisi R, Alvisi V, Volta CA. Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. Inflamm Res 2014; 63: 325-328.
149)Sarubbo S, Latini F, Ceruti S, Chieregato A, d'Esterre C, Lee TY, Cavallo M, Fainardi E. Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: a pilot study.Neuroradiology 2014; 56: 237-243.
150)Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggiani ML, Albani F, Baruzzi A, Pession A; PERNO study group. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol Oncol 2014; 8: 417-430.
151)Michelucci R, Pasini E, Meletti S, Fallica E, Rizzi R, Florindo I, Chiari A, Monetti C, Cremonini AM, Forlivesi S, Albani F, Baruzzi A; PERNO Study Group. Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study-Project of Emilia Romagna Region on Neuro-Oncology).Epilepsia 2013; 54 Suppl 7: 86-91.
152)Sarubbo S, Basso G, Chioffi F, Cesnik E, Paradiso B, Grandi E, Fainardi E, Tugnoli V, Farneti M, Granieri E. Technical, anatomical, and functional study after removal of a symptomatic cavernous angioma located in deep Wernicke's territories with cortico-subcortical awake mapping. Case Rep Neurol Med 2013; 2013: 835029.
153) Ceriotti C, Fabbian F, Fainardi E, Giusto L, Vanini A. Syncope as a manifestation of subclavian steal syndrome in an elderly patient with congestive heart failure. Eur Ger Med 2013; 4: 273-274.
154)Rizzo R, Trentini A, Bortolotti D, Manfrinato MC, Rotola A, Castellazzi M, Melchiorri L, Di Luca D, Dallocchio F, Fainardi E, Bellini T. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol Cell Biochem 2013; 381: 243-255.
155)Morandi F, Venturi C, Rizzo R, Castellazzi M, Baldi E, Caniatti ML, Tola MR, Granieri E, Fainardi E, Uccelli A, Pistoia V. Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.J Neuroimmune Pharmacol 2013; 8: 944-955.
156)Visani M, de Biase D, Marucci G, Taccioli C, Baruzzi A, Pession A; PERNO Study Group. Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PLoS One. 2013; 8: e55314.
157) Yeung TPC, Yartsev S, Bauman G,He W, Fainardi E, Lee T-Y. The effect of scan duration on the measurement of perfusion parameters in CT perfusions studies of brain tumors. Acad Radiol 2013; 20: 59-65.
158) Fainardi E, Borrelli M, Saletti A, Sarubbo S, Roversi G, Bernardoni A, Latini F, Azzini C, Borgatti L, De Vito A, Cavallo M, Ceruti S, Chieregato A. Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage. Neuroradiology 2013; 55: 145-156.
159)Rizzo R, Bortolotti D, Baricordi OR, Fainardi E. New insights into HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets2012; 11: 448-463.
160)Rizzo R, Bortolotti D, Fredj NB, Rotola A, Cura F, Castellazzi M, Tamborino C, Seraceni S, Baldi E, Melchiorri L, Tola MR, Granieri E, Baricordi OR, Fainardi E. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum Immunol 2012; 73:1140-1146.
161)d’Esterre CD, Fainardi E, Aviv RI, Lee TY. Improving acute stroke management with computed tomography perfusion: a review of imaging basics and application. Trasl Stroke Res 2012; 3: 205-220.
162)Sarubbo S, Latini F, Sette E, Milani P, Granieri E, Fainardi E, Cavallo MA. Is the resection of gliomas in Wernicke's area reliable? Wernicke's area resection.Acta Neurochir 2012; 154: 1653-1662.
163)De Biase D, Visani M, Morandi L, Marucci G, Taccioli C, Cerasoli S, Baruzzi A, Pession A; PERNO Study Group. miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.PLoS One 2012; 7: e35596.
164)Zuliani G, Guerra G, Dalla Nora E, Fainardi E. Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin.Aging Clin Exp Res 2011; 23: 498-500.
165)Bellini T, Trentini A, Manfrinato MC, Tamborino C, Volta CA, Di Foggia V, Fainardi E, Dallocchio F, Castellazzi M. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms.J Biochem 2012; 151: 493-499.
166)Holmøy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I. Intrathecal levels of vitamin D and IgG in multiple sclerosis.Acta Neurol Scand 2012; 125: e28-e31.
167)Casetta I, Fainardi E, Granieri E. An acutely confused young woman. Lancet 2011; 378: 456.
168)Sarubbo S, Latini F, Panajia A, Candela C, Quatrale R, Milani P, Fainardi E, Granieri E, Trapella G, Tugnoli V, Cavallo MA. Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up.Neurol Sci 2011; 32 801-810.
169)Saletti A, Morghen I, Finessi L, Fainardi E. Angioplasty in acute middle cerebral artery stroke due to atrial fibrillation selected by CT perfusion: a case report. Int J Emerg Med 2011; 4:23.
170)Fainardi E, Castellazzi M, Stignani M, Morandi F, Sana G, Gonzalez R, Pistoia V, Baricordi OR, Sokal E, Peña J. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 2011; 68:433-451.
171)Borgna-Pignatti C, Turlá G, Zanforlin N, Marsella M, Gentile MP, Maida G, Fainardi E. A calcified mass in the spinal canal of a patient with beta-thalassemia Major.J Pediatr Hematol Oncol 2011; 33: 79.
172)Borgna-Pignatti C, Turlá G, Zanforlin N, Marsella M, Gentile MP, Maida G, Fainardi E. A calcified mass in the spinal canal of a patient with beta-thalassemia Major.J Pediatr Hematol Oncol 2010; 32: 621.
173)Chieregato A, Tanfani A, Fainardi E. A practical approach to interpretation of CBF measured by mean of Xenon-CT in patients with traumatic brain injury. The Open Neurosurgery Journal 2010; 3: 28-58.
174)De Santis G, Ferracin M, Biondani A, Caniatti L, Tola MR, Castellazzi M, Zagatti B, Battistini L, Borsellino G, Fainardi E, Gavioli R, Negrini M, Furlan R, Granieri E. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 2010; 226:165-171.
175)Castellazzi M, Tamborino C, Cani A, Negri E, Baldi E, Seraceni S, Tola MR, Granieri E, Contini C, Fainardi E. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler. 2010; 16: 883-887.
176)Contini C, Seraceni S, Cultrera R, Castellazzi M, Granieri E, Fainardi E. Chlamydophila pneumoniae Infection and its Role in neurological disorders. Interdiscip Perspect Infect Dis 2010;2010:273573.
177)Lupato A, Fazio P, Fainardi E, Cesnik E, Casetta I, Granieri E. A case of asymptomatic pontine myelinolysis. Neurol Sci 2010; 31: 361-364.
178) Fabbian F, Pala M, Fallica E, Capone J, Monetti VC, Fratti D, Fainardi E. Posterior reversible encephalopathy syndrome in an 87-year-old woman with Escherichia coli bloodstream infection.Clin Exp Nephrol 2010; 14: 176-179.
179) Galiè M, Consorti G, Tieghi R, Denes SA, Fainardi E, Schmid JL, Neuschl M, Clauser L. Early surgical treatment in unilateral coronoid hyperplasia and facial asymmetry.J Craniofac Surg 2010; 21: 129-133.
180) Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V, Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK, Hintzen R, Ingelsson M, Jackson S, Jacobsen S, Jafari N, Jalosinski M, Jarius S, Kapaki E, Kieseier BC, Koel-Simmelink MJ, Kornhuber J, Kuhle J, Kurzepa J, Lalive PH, Lannfelt L, Lehmensiek V, Lewczuk P, Livrea P, Marnetto F, Martino D, Menge T, Norgren N, Papuć E, Paraskevas GP, Pirttilä T, Rajda C, Rejdak K, Ricny J, Ripova D, Rosengren L, Ruggieri M, Schraen S, Shaw G, Sindic C, Siva A, Stigbrand T, Stonebridge I, Topcular B, Trojano M, Tumani H, Twaalfhoven HA, Vécsei L, Van Pesch V, Vanderstichele H, Vedeler C, Verbeek MM, Villar LM, Weissert R, Wildemann B, Yang C, Yao K, Teunissen CE. Neurofilament ELISA validation. J Immunol Methods 2010; 352: 23-31.
181)Fainardi E, Di Biase F, Borrelli M, Saletti A, Cavallo M, Sarubbo S, Ceruti S, Tamarozzi R, Chieregato A. Potential role of CT perfusion parameters in the identification of solitary intra-axial brain tumor grading. Acta Neurochir 2010; 106 (Suppl): 283-287.
182) Fainardi E, Rizzo R, Lupato A, Ramponi V, De Santis G, Garofano F, Stignani M, Tamborino C, Castellazzi M, Casetta I, Baricordi OR. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta Neurochir 2010; 106 (Suppl): 141-145.
183) Castellazzi M, Tamborino C, De Santis G, Garofano F, Lupato A, Ramponi V, Trentini A, Casetta I, Bellini T, Fainardi E. Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta Neurochir 2010; 106 (Suppl): 137-140.
184) Fainardi E, Castellazzi M, Tamborino C, Seraceni S, Tola MR, Granieri E, Contini C. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms. J Neurovirol 2009; 15: 425-433.
185) Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, Casetta I. 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 2009; 15: 1280-1285.
186)Sarubbo S, Garofano F, Maida G, Fainardi E, Granieri E, Cavallo MA. Spontaneous and idiopathic chronic spinal epidural ematoma: two case reports and review of the literature. Eur Spine J 2009; 18: 1555-1561.
187)Fainardi E, Rizzo R, Castellazzi M, Stignani M, Granieri E, Baricordi OR. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis. Hum Immunol 2009; 70: 981-987.
188)Chieregato A, Noto A,Tanfani A, Bini G, Martino C, Fainardi E. Hyperemia beneath evacuated acute subdural hematoma is frequent and prolonged in patients with an unfavourable outcome: A Xenon-CT study. Neurosurgery 2009; 64: 705-718.
189) Fainardi E, Castellazzi M, Tamborino C, Trentini A, Manfrinato MC, Baldi E, Tola MR, Granieri E, Dallocchio F, Bellini T. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis. Mult Scler 2009; 15: 547-554.
190)Casetta I, Cesnik E, Fainardi E, Bonari L. An unusual cause of a common symptom: pyomyositis presenting with sciatica. Joint Bone Spine 2009; 76: 427-432.
191)Chieregato A, Tanfani A, Noto A, Fronza S, Cocciolo F, Fainardi E. Cerebral blood flow thresholds predicting new hypoattenuation areas due to macrovascular ischemia during the acute phase of severe and complicated aneurysmal subarachnoid hemorrhage. A preliminary study. Acta Neurochir 2008; 102 (Suppl): 311-316.
192)Chieregato A, Fainardi E. Potential role of surgery in traumatic focal brain lesions as revealed by functional imaging. Intensive Care Med 2008;34: 2125-2126.
193)Contini C, Seraceni S, Castellazzi M, Granieri E, Fainardi E. Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis. Neurosci Res 2008; 62: 58-61.
194)Contini C, Seraceni S, Cultrera R, Castellazzi M, Granieri E, Fainardi E. Molecular detection of parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis. Mult Scler 2008; 14: 564-566.
195)Fainardi E, Borrelli M, Saletti A, Schivalocchi R, Azzini C, Cavallo M, Ceruti S, Tamarozzi R, Chieregato A. CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage. Neuroradiology 2008; 50: 729-740.
196)Mameli G, Serra C, Astone V, Castellazzi M, Poddighe L, Fainardi E, Neri W, Granieri E, Dolei A. Inhibition of multiple sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol 2008; 14: 73-77.
197)Fainardi E, Castellazzi M, Seraceni S, Granieri E, Contini C. Under the microscope: focus on chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 2008; 5: 60-70.
198)Fainardi E, Rizzo R, Melchiorri L, Stignani M, Castellazzi M, Tamborino C, Paolino E, Tola MR, Granieri E, Baricordi OR. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis. Mult Scler 2008; 14: 446-454.
199) Arru G, Mameli G, Astone V, Serra C, Huang YM, Link H, Fainardi E, Castellazzi M, Granieri E, Fernandez M, Villoslada P, Fois ML, Sanna A, Rosati G, Dolei A, Sotgiu S. Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci 2007; 3: 292-297.
200)Granieri E, Economou NT, De Gennaro R, Tola MR, Caniatti L, Govoni V, Fainardi E, Casetta I. Multiple sclerosis in the province of Ferrara: Evidence for an increasing trend. J Neurol. 2007; 254: 1642-1648.
201)Fainardi E, Rizzo R, Melchiorri L, Stignani M, Castellazzi M, Caniatti ML, Baldi E, Tola MR, Granieri E, Baricordi OR. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2007; 192: 219-225.
202) Chieregato A, Marchi M, Fainardi E, Targa L. Cerebral arterio-venous pCO2 difference, estimated respiratory quotient, and early posttraumatic outcome: comparison with arterio-venous lactate and oxygen differences. J Neurosurg Anesthesiol. 2007; 19: 222-228.
203)Fainardi E, Castellazzi M, Bellini T, Dallocchio F. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies. Mult Scler 2007; 13: 691-692.
204)Chieregato A, Tanfani A, Compagnone C, Turrini C, Sarpieri F, Ravaldini M, Targa L, Fainardi E. Global cerebral blood flow and CPP after severe head injury: a xenon-CT study. Intensive Care Med. 2007; 33: 856-62.
205)Chieregato A, Tanfani A, Compagnone C, Pascarella R, Targa L, Fainardi E. Cerebral blood flow in traumatic contusions is predominantly reduced after an induced acute elevation of cerebral perfusion pressare. Neurosurgery 2007; 60: 115-123.
206)Volta CA, Alvisi V, Campi M, Marangoni E, Alvisi R, Castellazzi M, Fainardi E, Manfrinato MC, Dallocchio F, Bellini T.Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study.Anesthesiology. 2007; 106: 85-91.
207)Fainardi E, Tagliaferri F, Compagnone C, Tanfani A, Cocciolo F, Battaglia R, Frattarelli M, Pascarella R, Targa L, Chieregato A. Regional cerebral blood flow levels as measured by xenon-CT in vascular territorial low-density areas after subarachnoid hemorrhage are not always ischemic. Neuroradiology 2006; 48: 685-690.
208)Castellazzi M, Tamborino C, Fainardi E, Manfrinato MC, Granieri E, Dallocchio F, Bellini T. Effects of anticoagulants on the activity of gelatinases. Clin Biochem 2007; 40: 1272-1276.
209) Fainardi E, Castellazzi M, Bellini T, Manfrinato MC, Baldi E, Casetta I, Paolino E, Granieri E, Dallocchio F. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 2006; 12: 294-301.
210)Tagliaferri F, Compagnone C, Fainardi E, Tanfani A, Pascarella R, Sarpieri F, Targa L, Chieregato A. Reperfusion of low attenuation areas complicating subarachnoid hemorrage. Acta Neurochir 2006; 96 (Suppl): 85-87.
211)Fainardi E, Borrelli M, Saletti A, Schivalocchi R, Russo M, Azzini C, Cavallo M, Ceruti S, Tamarozzi R, Chieregato A. Evaluation of perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging. Acta Neurochir 2006; 96 (Suppl): 81-84.
212) Compagnone C, Tagliaferri F, Fainardi E, Tanfani A, Pascarella R, Ravaldini M, Targa L, Chieregato A. Diagnostic impact of the spectrum of ischemic cerebral blood flow thresholds in sedated subarachnoid hemorrage patients. Acta Neurochir 2006; 96 (Suppl): 53-56.
213)Fainardi E, Rizzo R, Melchiorri L, Castellazzi M, Paolino E, Tola MR, Granieri E, Baricordi OR. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler 2006; 12: 2-12.
214)Chieregato A, Compagnone C, Tanfani A, Ravaldini M, Tagliaferri F, Pascarella R, Servadei F, Targa L, Fainardi E. Cerebral blood flow mapping in two different subtypes of intraparenchymal hemorrhagic traumatic lesions. Acta Neurochir 2005; 95 (Suppl): 159-164.
215)Chieregato A, Tagliaferri F, Tanfani A, Cocciolo F, Benedettini W, Compagnone C, Ravaldini M, Pascarella R, Battaglia R, Frattarelli M, Targa L, Fainardi E. Cerebral blood flow in mean cerebral artery low density areas is not always ischemic in patients with aneurysmal subarachnoid hemorrage-relationship with neurological outcome. Acta Neurochir 2005; 95 (Suppl): 153-158.
216)Chieregato A, Marchi M, Compagnone C, Albarello V, Fainardi E, Tagliaferri F, Targa L. Estimated cerebral respiratory quotient and arteriovenous differences of CO2 in the ultra early detection of global ischemia in severe head injury. Acta Neurochir 2005; 95 (Suppl): 67-71.
217)Fainardi E, Borrelli M, Saletti A, Schivalocchi R, Russo M, Azzini C, Cavallo M, Ceruti S, Chieregato A, Tamarozzi R. Assessment of acute spontaneous intracerebral ematoma by CT perfusion imaging. J Neuroradiol 2005; 32: 333-336.
218)Chieregato A, Fainardi E. Fisiopatologia del focolaio lacero-contusivo. Neurol Sci 2005; 26: S539-S542.
219) Chieregato A, Fainardi E, Morselli-Labate AM, Antonelli V, Compagnone C, Targa L, Kraus J, Servadei F. Factors associated to neurological outcome and lesion progression in traumatic subarchnoid hemorrhage patients. Neurosurgery 2005; 56: 671-680.
220)Contini C, Cultrera R, Seraceni S, Castellazzi M, Granieri E, Fainardi E. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult Scler. 2004; 10: 360-369.
221)Chieregato A, Fainardi E, Servadei F, Tanfani A, Pugliese G, Pascarella R, Targa L. Centrifugal distribution of regional cerebral blood flow and its time course in traumatic intracerebral hematomas. J Neurotrauma. 2004; 21:655-666.
222)Fainardi E, Chieregato A, Antonelli V, Fagioli L, Servadei F. Time course of CT evolution in traumatic subarachnoid haemorrage: a study of 141 patients. Acta Neurochir 2004; 146: 257-263.
223)Fainardi E, Rizzo R, Melchiorri L, Castellazzi M, Govoni V, Caniatti L, Paolino E, Tola MR, Granieri E, Baricordi OR. Beneficial effect of interferon-β 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of theraphy. J Neuroimmunol 2004; 148: 206-211.
224)Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E, Contini C. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. J Neurol Sci 2004; 217: 181-188.
225)Chieregato A, Fainardi E, Tanfani A, Sabia G, Martino C, Pascarella R, Servadei F, Targa L. Induced acute arterial hypertension and regional cerebral blood flow in intracontusional low density area. Acta Neurochir 2003; 86 (Suppl): 361-365.
226)Chieregato A, Fainardi E, Tanfani A, Pransani V, G, Cocciolo F, Targa L, Servadei F. Mixed dishomogeneous hemorrhagic brain contusions. Mapping of cerebral blood flow. Acta Neurochir 2003; 86 (Suppl): 333-337.
227)Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A, Govoni V, Paolino E, Tola MR, Granieri E, Baricordi OR. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF solubile HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 2003; 142: 149-158.
228)Fainardi E, Borrelli M, Saletti A, Schivalocchi R, Russo M, Azzini C, Cavallo M, Ceruti S, Tamarozzi R. Cerebral blood flow within and around acute spontaneous intracerebral haematoma. A CT perfusion study. Rivista di Neuroradiologia 2003; 16 (Suppl 1): 262-264.
229) Contini C, Fainardi E, Seraceni S, Granieri E, Castellazzi M, Cultrera R.Molecular Identification and Antibody Testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-Associated Dementia Complex. Preliminary results. J Neuroimmunol 2003; 136: 172-177.
230)Servadei F, Antonelli V, Betti L, Chieregato A, Fainardi E, Gardini E, Giuliani G, Salizzato L, Kraus JF. Regional brain injury epidemiology as the basis for planning brain injury treatment. J Neurosurg Sci 2002; 46: 111-119.
231)Fainardi E, Granieri E, Tola MR, Melchiorri L, Vaghi L, Rizzo R, Castellazzi M, Ceruti S, Paolino E, Baricordi OR. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules. J Neuroimmunol 2002; 133:151-159.
232)Contini C, Cultrera R, Seraceni S, Segala D, Romani R, Fainardi E, Cinque P, Lazzarin A, Delia S.The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS. J Med Microbiol 2002; 51: 879-890.
233)Casetta I, Monetti VC, Malagù S, Paolino E, Govoni V, Fainardi E, Tola MR, Granieri E.Risk factors for cryptogenic and idiopathic partial epilepsy: a community-based case-control study in Copparo, Italy. Neuroepidemiology 2002; 21: 251-544.
234)Servadei F, Antonelli V, Giuliani G, Fainardi E, Chieregato A, Targa L.Evolving lesions in traumatic subarachnoid hemorrhage: prospective study of 110 patients with emphasis on the role of ICP monitoring. Acta Neurochir Suppl 2002; 81: 81-82.
235)Fainardi E, Chieregato A, Mariottini L, Pascarella R, Matassoni L, Giovannini A, Servadei F, Targa L, Fagioli L. Cerebral blood flow in traumatic contusions. Rivista di Neuroradiologia 2001; 14 (Suppl 3): 171-174.
236)Fainardi E, Contini C, Benassi N, Bedetti A, Castellazzi M, Vaghi L, Govoni V, Paolino E, Balboni P, Granieri E. Assessment of HIV intrathecal humoral immune response in AIDS-related neurological disorders. J Neuroimmunol2001; 119: 278-86.
237)Contini C, Fainardi E, Cultrera R, Seraceni S, Castellazzi M, Peyron F, Granieri E. Evidence of cerebrospinal fluid free kappa light chain in AIDS patients with Toxoplasma gondii encephalitis. J Neuroimmunol2000; 108: 221-226.
238)Contini C, Cultrera R, Fainardi E, Seraceni S, Castellazzi M, Monda V, Granieri E. Aspetti diagnostici biomolecolari e immunologici della toxoplasmosi in corso di AIDS. Giornale Italiano di Malattie Infettive 1999; 5 (Suppl 3): S245-S251.
239)Paolino E, Fainardi E, Vaghi L, Castellazzi M, Granieri E. Le alterazioni liquorali nella neurosifilide sintomatica. Rivista di Neurobiologia 1999; 45: 43-47.
240)Paolino E, Fainardi E, Vaghi L, Castellazzi M, Carreras M. Inter-observer agreement nell'interpretazione di pattern diversi di immunoblotting IgG-specifico. Rivista di Neurobiologia 1998; 44: 481-484.
241)Vaghi L, Fainardi E, Carreras M, Castellazzi M, Paolino E. Agreement tra analisi qualitativa e quantitativa nella valutazione di una sintesi intratecale di immunoglobuline. Rivista di Neurobiologia 1998; 44: 477- 480.
242) Contini C, Fainardi E, Cultrera R, Canipari R, Peyron F, Delia S, Paolino E, Granieri E. Advanced laboratory techniques for diagnosing Toxoplasma Gondii encephalitis in AIDS patients: significance of intratecal production and comparison with PCR and ECL-western blotting. J Neuroimmunol1998; 92: 29-37.
243)Ferrante P, Omodeo-Zorini E, Caldarelli-Stefano R, Mediati M, Fainardi E, Granieri E. Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler 1998; 4: 49-54.
244)Govoni V, Granieri E, Tola MR, Ruppi P, Vaghi L, Fainardi E. Evaluation of the risk of developing motor neuron disease in the province of Ferrara, Northern Italy. Descriptive study. Environment and neurological diseases, A & J Roma 1997; 65-72.
245)Govoni V, Granieri E, Tola MR, Paolino E, Casetta I, Fainardi E, Monetti VC. Exogenous gangliosides and Guillain-Barré syndrome. An observation study in the Local Health District of Ferrara, Italy. Brain 1997; 120: 1123-1130.
246)Fainardi E, Paolino E, Ruppi P, Bedetti A, Govoni V, Casetta I, Tola MR, Granieri E, Monetti VC, Ghinelli F, Carreras M. Utilità della valutazione del profilo liquorale in pazienti affetti da AIDS. L' Arcispedale S. Anna 1996; XLVI, n.2: 261-266.
247)Paolino E, Fainardi E. L'analisi liquorale nella Sclerosi Multipla ed in altri disordini neurologici. L' Arcispedale S. Anna 1996; XLVI, n.2: 227-237.
248)Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, Fainardi E, Monetti VC. Aumento dell'incidenza della sindrome di Guillain-Barré a Ferrara, 1981-1993. Ambiente e Malattie del Sistema Nervoso, A & J Roma, 1996; 84-90.
249) Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, Fainardi E, Monetti VC. The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? J Neurol Sci 1996; 137: 62-68.
250) Paolino E, Fainardi E, Ruppi P, Tola MR, Govoni V, Casetta I, Monetti VC, Granieri E, Carreras M. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 572-575.
251)Govoni V, Granieri E, Tola MR, Casetta I, Paolino E, Monetti VC, Fainardi E. Il contributo dell'epidemiologia alla ricerca eziologica sul Morbo di Parkinson. L' Arcispedale S. Anna 1995; XLV, n.2: 71-85.
252) Paolino E, Fainardi E, Ruppi P, Tola MR, Govoni V, Casetta I, Monetti VC, E. Granieri E, Carreras M. Alterazioni liquorali nella sindrome di Guillain-Barrè: utilità nella diagnosi e monitoraggio della malattia. Rivista di Neurobiologia 1995; 41: 681- 686.
253) Paolino E, Fainardi E, Addonizio MC, Casetta I, Govoni V, Monetti VC, Tola MR, Granieri E, Carreras M. Sintesi intratecale di IgG in diverse patologie del nevrasse: confronto fra le varie formule con il "gold standard" dell'isoelettrofocusing. Rivista di Neurobiologia 1994; 40: 33-42.
254) Paolino E, Fainardi E, Addonizio MC, Ruppi P, Casetta I, Granieri E, Carreras M. La sintesi intratecale di IgM nella Sclerosi Multipla ed in altri disordini neurologici. Rivista di Neurobiologia 1994; 40: 27-32.
255) Paolino E, Fainardi E, Addonizio MC, Pascarella R, Casetta I, Govoni V, Tola MR, Granieri E, Carreras M. Le catene leggere kappa e lambda nella Sclerosi Multipla ed in altri disordini neurologici. Rivista di Neurobiologia 1994; 40: 23-26.
256) Govoni V. Granieri E, Tola MR, Casetta I, Monetti VC, Fainardi E, Paolino E. Prevalence of anti-parkinson drugs' use in Ferrara, Northern Italy, 1988. Acta Neurol Scand 1994; 89: 433-438.
257) Casetta I, Granieri E, Malagù S, Tola MR, Paolino E, Caniatti LM, Govoni V, Monetti VC, Fainardi E. Environmental risk factor and Multiple Sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994; 13: 120-128.
258) Govoni V, Casetta I, Granieri E, Veronesi V, Malagù S, Tola MR, Paolino E, Fainardi E, Monetti VC, Aiello I. Mortality study on Multiple Sclerosis in the province of Ferrara, Northern Italy, 1968 through 1989. Acta Neurologica New Series 1993; 15; 161-176.
259) Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, Fainardi E, Monetti VC. Fattori ambientali nella genesi delle sindromi parkinsoniane? Disomogenea frequenza degli assuntori di farmaci antiparkinsoniani a Ferrara. Fattori Ambientali e Patologie del Sistema Nervoso, Edi-Lombardo Roma, 1993; 113-118.
260) Granieri E, Casetta I, Malagù S, Tola MR, Paolino E, Caniatti LM, Govoni V, Monetti VC, Fainardi E. Ambiente e Sclerosi Multipla: studio caso-controllo a Ferrara. Fattori Ambientali e Patologie del Sistema Nervoso, Edi-Lombardo Roma, 1993; 85-90.
261) Paolino E, Govoni V, Calzolari F, Tamarozzi R, Pinna L, Tola MR, Fainardi E, Granieri E. Mielopatie cervicali compressive da cause rare: analisi clinica e neuroradiologica. Rivista di Neurobiologia 1992; 38: 165-170.
262) Granieri E, Rosati G, Tola MR, Paolino E, Carreras M, Monetti VC, Aiello I, Casetta I, Govoni V, Caniatti L, Malagù S, D'Alessandro R, Pavoni M, Casimiro M, Benassi G, Gamberini G, Altobelli A, Fainardi E. Le malattie neurologiche negli anni ottanta: neuroepidemiologia descrittiva in provincia di Ferrara e in Sardegna. Epidemiologia e Prevenzione 1991; n° 48-49: 160-166.
263) Granieri E, Carreras M, Paolino E, Tola R, Govoni V, Casetta I, Monetti VC, Malagù S, Fainardi E, Vicentini V. Incidence of Parkinson disease in Ferrara, Northern Italy. Proceedings of European Conference on Parkinson Disease and Extrapyramidal Disorders, Rome July 10-14, 1990. Pathophysiology and Treatment 1991; 229-234.
Capitoli su libri scientifici
4 capitoli su libri scientifici:
1) Fainardi E. Ruolo dell’imaging. In: Tarantini G, Esposito G, Musumeci G (Ed.). Interventistica cardiovascolare nella prevenzione e trattamento dello stroke. Minerva Medica Editore. 2020; 12-23.
2) Fainardi E. Selezione all’intervento endovascolare tra perfusione e circoli collaterali. In: Mangiafico S (Ed.). Interventistica Neurovascolare. Poletto Editore. Milano; 2017: 369-389.
3) Fainardi E, Castellazzi M. Neuroimmune interactions that operate in the development and progression of inflammatory demyelinating diseases: lessons from pathogenesis of multiple sclerosis. In: Maiese K (Ed.). Neurovascular medicine. Pursuing cellular longevity for healthy aging. 1st ed. Oxford University Press: New York; 2009: 291-318.
4) Fainardi E, Ceruti S, Tamarozzi R. Distretto encefalico. In: Protocolli applicativi per MSCT. Versione ottimizzata per scanners di ultima generazione-64 strati. GE Healthcare. Sintesi Infomedica. Milano; 2010: 19-37.
Legenda
Date and place of birth: Parma (Italy), September 9th, 1961
Nationality: Italian
Affiliation: Struttura Organizzativa Dipartimentale di Neuroradiologia, Dipartimento di Scienze Biomediche, Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze, Largo Palagi 1, Firenze 50139, Italy
Telephone +39-055-7948638
Fax +39-055-7948325
e-mail doctor.arkadin@gmail.com,enrico.fainardi@unifi.it, fainardie@aou-careggi.toscana.it
1988: University of Parma (Italy) Medical School: MD.
1992: University of Ferrara (Italy) Medical School: Neurology Certification, with honours.
1998: University of Ancona (Italy) Medical School: PhD in Neurological and Neurosensorial Sciences
1998-2001: Medical Assistant in Neuroradiologist Azienda Ospedaliera Cesena, Italy
2001: University of Ferrara (Italy) Medical School: Radiology Certification, with honours
2001-2016: Medical Assistant in Neuroradiologist, Azienda Ospedaliero-Universitaria, Ferrara, Italy
2017: University of Florence (Italy)Medical School: Associate Professor of Neuroradiology
2018: Italian Ministry of Health: National Scientific Qualification as Full Professor of Neuroradiology
2016-today: Head of Neurology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
EDUCATION/TRAINING
COURSES
1995/1996: University of Göttingen (Germany): Intensive Course on Cerebrospinal Fluid
1997: Vienna (Austria): First intensive Course on Neuroimmunology
1999: Bergamo (Italy): First Residential Course of Neuroimmunology
2000: University of Parma (Italy): MRI Basic-Advanced Course
2004: Bergamo (Italy): Sixth Residential Course of Neuroimmunology
2004: Venice (Italy): Fifth Course of the European School of Neuroimmunology
CAREER/EMPLOYMENT
1993-1994: AUSL di Ferrara (Italy): Neurology, Specialist
1996: INAIL di Ferrara (Italy): Neurology, Specialist
TEACHING EXPERIENCES
2001-2016: Professor at the Post-degree school in Neurosurgery, University of Ferrara, Italy.
2001-2016: Professor at the Post-degree school in Internal Medicine, University of Ferrara, Italy.
2003-2016: Professor at the Post-degree school in Neurology, University of Ferrara, Italy
2010-2016: Professor at the Post-degree School in Radiology, University of Ferrara, Italy
2012-2016: Professor at the Post-degree School in Infectious Diseases, University of Ferrara, Italy
2016-today: Professor at the School of Medicine, University of Florence, Italy
2016-today: Professor at the Post-degree school in Neurosurgery, University of Florence, Italy
2016-today: Professor at the Post-degree school in Internal Medicine, University of Florence, Italy
2016-today: Professor at the Post-degree school in Neurology, University of Florence, Italy
2016-today: Professor at the Post-degree School in Radiology, University of Florence, Italy
RESEARCH EXPERIENCES/COLLABORATIONS
1996: Laboratory of Neurochemistry, University of Göttingen (Germany): Neuroimmunology
1997-today: Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Institute, Milano
1998-2001: Neurosurgery Unit, Ospedale M. Azienda Ospedaliera di Cesena (Italy): Neuroradiology: Neuroimmunology
2009-2012: Dept. of Radiology Tulln University Hospital, University of Vienna (Austria): Neuroradiology
2009-2013: Fondazione Don Carlo Gnocchi, Milan (Italy): Neuroradiology
2011-today: Department of Medical Imaging, Lawson Health Research Institute and Imaging Research Lab, Robarts Research Institute, Western University, London, Ontario (Canada): Neuroradiology
2011: Laboratory of Oncology, G. Gaslini Scientific Institute, Genoa, (Italy): Neuroimmunology
2011: Laboratory of Cardiology, University of Geneva (Switzerland): Neuroimmunology
2012: Dept. of Neurology, University of Belgrade (Serbia): Neuroimmunology
2012-today:Hematology Institute, Hôpital Saint-Louis, Paris (France): Neuroimmunology
2013-today: Calgary Stroke Program, Department of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, Alberta, Canada:Neuroradiology
2015-today: Dipartimento di Medicina e Specialità Mediche, Università degli Studi di Genova, Italy: Neuroimmunology and Neuroradiology
2015-today: Istituto di Ricerche Farmacologiche Mario Negri, Centro di Ricerche Cliniche per le Malattie Rare “Aldo e Cele Daccò”, Bergamo, Italy: Neuroimmunology and Neuroradiology
PROFESSIONAL APPOINTMENTS
2009: 5th International Conference on HLA-G, Paris (France): Member of Scientific Advisory Board
2012: 6th International Conference on HLA-G, Paris (France): Member of Scientific Advisory Board
2012-2016: Dept. of Neuroscience and Rehabilitation, Azienda Ospedaliero-Universitaria Arcispedale S. Anna, Ferrara (Italy): Member of Scientific Advisory Board
2015: 7th International Conference on HLA-G, Paris (France): Member dello Scientific Advisory
Board
AWARDS
1993: winner of the “Architetto Andrea Donati” prize for young physicians, University of Ferrara.
2003: academic title of “Expert in Neurology”, University of Ferrara
PROFESSIONAL SOCIETIES
1995: Member of the “European Quality Assurance Scheme” for oligoclonal bands in cerebrospinal fluid analysis. Coordinator Prof. E.J. Thompson (U.K.)
1996: Member of the “CSF Research Group of the World Federation of Neurology”.
1998: Participation at the “External Quality Assessment - Cerebrospinal Fluid Survey”, coordinator Prof. H. Reiber (Germany)
1998-today. Member of Associazione Italiana Neuroimmunologia (AINI)
2006-2016: AINI Regional Coordinator
2007-today: Member of BioMS-eu Consortium for CSF Biomarker research in MS
2013-today: Member of Italian Society of Medical Radiology (SIRM)
2016-today: Member of Italian Association of Neuroradiology (AINR)
2016-oggi: Member of Italian Stroke Organization (ISO)
Research Grant
2003-2004: Biological role of soluble HLA-G antigens in Multiple Sclerosis, Fondazione Italiana Sclerosi Multipla
2007-2010: Nuove conoscenze e problematiche assistenziali nell’ictus cerebrale: un programma stategico di ricerca e sviluppo-Studio dei marker biologici, neurofisiologici, e Neuroradiologici associati all’ictus ischemico, Italian National Health System
2007-2010: A primary brain tumours registry as a framework for promoting clinical research in Neuro-Oncology: Project of Emilia-Romagna region on Neuro-Oncology (PERNO)-Prognostic value of neuroradiological examinations in primary brain tumours, Emilia Romagna Region
2009-2010:Molecular and humoral immune characterization of Epstein-Barr virus brain persistence and its peripheral T cell regulatory mechanisms in multiple sclerosis, Fondazione Italiana Sclerosi Multipla
2012: Evolution of Cerebral Hemodynamics and Blood-Brain Barrier Disturbances After Acute Ischemia Stroke: A CT Perfusion Imaging Study, European Stroke Network (ESN)/Canadian Stroke Network (CSN)
2015: “Precise and Rapid assessment of collaterals using multi-phase CTA in the triage of patients with acute ischemic stroke for IA Therapy (“PRove-IT”)”
REVIEWER FOR
o) La Radiologia Medica
PUBLICATIONS
236 original articles, 4 book chapter, more than 260 meeting abstracts.
Scopus (2023, September): 35
Original articles and reviews:
3)Pezzini D, Nawabi J, Schlunk F, Li Q, Mazzacane F, Busto G, Scola E, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Cavallini A, Katsanos AH, Shoamanesh A, Zini A, Casetta I, Fainardi E, Morotti A, Padovani A. Predictors and prognostic impact of hematoma expansion in infratentorial cerebral hemorrhage. Neurocrit Care 2023 Sep 5 [Online ahead of print].
4)Lotti A, Barilaro A, Mariottini A, Vannozzi L, Piergentili M, Fainardi E, Massacesi L. Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management. Front Neurol 2023;14: 1201643.
6)Mariottini A, Lotti A, Innocenti C, Repice AM, Nozzoli C, Boncompagni R, Fainardi E, Saccardi R, Massacesi L. Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation. Eur J Neurol 2023 Jul 22 [Online ahead of print].
7)Rebchuk AD, Hill MD, Goyal M, Demchuk A, Coutts SB, Asdaghi N, Dowlatshahi D, Holodinsky JK, Fainardi E, Shankar J, Najm M, Rubiera M, Khaw AV, Qiu W, Menon BK, Field TS. Exploring sex differences for acute ischemic stroke clinical, imaging, and thrombus characteristics in the INTERRSeCT study. J Cereb Blood Flow Metab 2023 Jul 17 [Online ahead of print].
9)Cappellari M, Saia V, Pracucci G, Casetta I, Fainardi E, Sallustio F, Ruggiero M, Romoli M, Simonetti L, Zini A, Lazzarotti GA, Orlandi G, Vallone S, Bigliardi G, Renieri L, Nencini P, Semeraro V, Boero G, Bracco S, Tassi R, Castellano D, Naldi A, Biraschi F, Nicolini E, Del Sette B, Malfatto L, Allegretti L, Tassinari T, Tessitore A, Ferraù L, Saletti A, De Vito A, Lafe E, Cavallini A, Bergui M, Bosco G, Feraco P, Bignamini V, Mandruzzato N, Vit F, Mardighian D, Magoni M, Comelli S, Melis M, Menozzi R, Scoditti U, Cester G, Viario F, Stecco A, Fleetwood T, Filauri P, Sacco S, Giorgianni A, Cariddi LP, Piano M, Motto C, Gallesio I, Sepe F, Romano G, Grasso MF, Lozupone E, Fasano A, Comai A, Franchini E, Bruni S, Silvestrini M, Chiumarulo L, Petruzzelli M, Pavia M, Invernizzi P, Puglielli E, Casalena A, Pedicelli A, Frisullo G, Amistà P, Russo M, Allegritti M, Caproni S, Mangiafico S, Toni D; IRETAS Group. Stroke with large vessel occlusion in the posterior circulation: IV thrombolysis plus thrombectomy versus IV thrombolysis alone. J Thromb Thrombolysis 2023 Jun 28 [Online ahead of print].
10)Busto G, Morotti A, Carlesi E, Fiorenza A, Di Pasquale F, Mancini S, Lombardo I, Scola E, Gadda D, Moretti M, Miele V, Fainardi E. Pivotal role of multiphase computed tomography angiography for collateral assessment in patients with acute ischemic stroke. Radiol Med 2023; 128: 944-959.
11)Cappellari M, Pracucci G, Saia V, Sallustio F, Casetta I, Fainardi E, Capasso F, Nencini P, Vallone S, Bigliardi G, Saletti A, De Vito A, Ruggiero M, Longoni M, Semeraro V, Boero G, Silvagni U, Stancati F, Lafe E, Mazzacane F, Bracco S, Tassi R, Comelli S, Melis M, Romano D, Napoletano R, Menozzi R, Scoditti U, Chiumarulo L, Petruzzelli M, Vinci SL, Ferraù L, Taglialatela F, Zini A, Sanna A, Tassinari T, Iacobucci M, Nicolini E, Bergui M, Cerrato P, Giorgianni A, Princiotta Cariddi L, Amistà P, Russo M, Gallesio I, Sepe F, Comai A, Franchini E, Filauri P, Orlandi B, Besana M, Giossi A, Lazzarotti GA, Orlandi G, Castellano D, Naldi A, Plebani M, Zivelonghi C, Invernizzi P, Mangiafico S, Toni D. Predictors for hemorrhagic transformation and cerebral edema in stroke patients with first-pass complete recanalization. Int J Stroke 2023 Jun 19 [Online ahead of print].
12)Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D, Mancini S, Carlesi E, Moretti M, Desideri I, Muscas G, Della Puppa A, Fainardi E. Conventional and advanced magnetic resonance imaging assessment of non-enhancing peritumoral area in brain tumor. Cancers 2023; 15: 2992.
13)Sperti M, Arba F, Acerbi A, Busto G, Fainardi E, Sarti C. Determinants of cerebral collateral circulation in acute ischemic stroke due to large vessel occlusion. Front Neurol 2023; 14: 1181001.
14)Gentile L, Pracucci G, Saia V, Falcou A, Biraschi F, Zini A, Simonetti L, Riva L, Bigliardi G, Vallone S, Nencini P, Limbucci N, Diomedi M, Da Ros V, Longoni M, Ruggiero M, Tassinari T, Allegretti L, Cerrato P, Rubino E, Bergui M, Cavallo R, Naldi A, Comelli C, Cappellari M, Zivelonghi C, Plebani M, De Vito A, Merli N, Saletti A, Musolino RF, Ferraù L, Vinci SL, Sacco S, Orlandi B, De Santis F, Filauri P, Ruiz L, Sepe FN, Gallesio I, Petruzzellis M, Chiumarulo L, Sangalli D, Salmaggi A, Filizzolo M, Moller J, Melis M, Comelli S, Magoni M, Gilberti N, Gasparotti R, Invernizzi P, Pavia M, Pinto V, Laspada S, Marcheselli S, Ajello D, Viaro F, Baracchini C, Causin F, Giannini N, Caselli MC, Mancuso M, Cosottini M, Scoditti U, Menozzi R, Russo M, Amistá P, Napoletano R, Romano DG, Tassi R, Bracco S, Carimati F, Versino M, Giorgianni A, De Boni A, Fasano A, Barbarini L, Paladini A, Franchini E, Dall'Ora E, Comai A, Giovanni F, Pedicelli A, Sallustio F, Casetta I, Fainardi E, Mangiafico S, Toni D; Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS) Collaborators. Mechanical thrombectomy in patients with heart failure: the Italian registry of Endovascular Treatment in Acute Stroke. Neurol Sci 2023 May 18 [Online ahead of print].
15)Cappellari M, Saia V, Pracucci G, Fainardi E, Casetta I, Sallustio F, Nencini P, Bigliardi G, Saletti A, Ruggiero M, Da Ros V, Castellan L, Tassi R, Mandruzzato N, Toni D, Mangiafico S; IRETAS group. Predictors for clinical and functional outcomes in stroke patients with first-pass complete recanalization after thrombectomy. Eur J Neurol 2023; 30: 2288-2296.
16)Fainardi E, Busto G, Scola E, Casetta I, Mizutani K, Consoli A, Boulouis G, Padovani A, Morotti A. Perfusion gradients promote delayed perihaematomal oedema in intracerebral haemorrhage. Brain Commun 2023; 5: fcad133.
17)Chen ZF, Zhang L, Carrington AM, Thornhill R, Miguel O, Auriat AM, Fard NO, Hiremath S, Tshemeister Abitbul V, Dowlatshahi D, Demchuk A, Gladstone D, Morotti A, Casetta I, Fainardi E, Huynh T, Elkabouli M, Talbot Z, Melkus G, Aviv RI. Clinical features, non-contrast CT radiomic and radiological signs in models for the prediction of hematoma expansion in intracerebral hemorrhage. Can Assoc Radiol J 2023 Apr 18 [Online ahead of print].
18)Bala F, Kim BJ, Najm M, Thornton J, Fainardi E, Michel P, Alpay K, Herlihy D, Goyal M, Casetta I, Nannoni S, Ylikotila P, Power S, Saia V, Hegarty A, Pracucci G, Rautio R, Ademola A, Demchuk A, Mangiafico S, Boyle K, Hill MD, Toni D, Murphy S, Menon BK, Almekhlafi MA; Selection of Late-window Stroke for Thrombectomy by Imaging Collateral Extent (SOLSTICE) Consortium. Outcomes with endovascular treatment of patients with M2 Segment MCA occlusion in the late time window. AJNR Am J Neuroradiol 2023; 44: 447-452.
19)Naldi A, Pracucci G, Cavallo R, Saia V, Boghi A, Lochner P, Casetta I, Sallustio F, Zini A, Fainardi E, Cappellari M, Tassi R, Bracco S, Bigliardi G, Vallone S, Nencini P, Bergui M, Mangiafico S, Toni D; Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS) Investigators. Mechanical thrombectomy for in-hospital stroke: data from the Italian Registry of Endovascular Treatment in Acute Stroke. J Neurointerv Surg 2023 Mar 7 [Online ahead of print].
20)Toffali M, Carbone F, Fainardi E, Morotti A, Montecucco F, Liberale L, Padovani A. Secondary Prevention after Intracerebral Hemorrhage. Eur J Clin Invest 2023; 53: e13962.
21)Muscas G, Pisano A, Carrai R, Bianchi A, Capelli F, Montemurro VM, Martinelli C, Fainardi E, Grippo A, Della Puppa A. A diffusion tensor imaging-based prognostic classification for surgery of intrinsic lesions involving the motor pathways. World Neurosurg 2023; 172: e565-e573.
22)Salvadori E, Barucci E, Barbato C, Formelli B, Cesari F, Chiti S, Diciotti S, Giusti B, Gori AM, Marzi C, Pescini F, Pracucci G, Fainardi E, Marcucci R, Poggesi A. Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation. Strat-AF Study. Eur J Neurol 2023 30: 849-860.
23)Imreh S, Gadda D, Pandolfo C, Pellicanò G, Fainardi E. Post‑Traumatic haemorrhagic Tarlov’s cyst: a case report and review of literature. SN Compr Clin Med 2023; 5: 55.
25)Morotti A, Boulouis G, Nawabi J, Li Q, Charidimou A, Pasi M, Schlunk F, Shoamanesh A, Katsanos AH, Mazzacane F, Busto G, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Warren AD, Laudisi M, Cavallini A, Gurol EM, Viswanathan A, Zini A, Casetta I, Fainardi E, Greenberg SM, Padovani A, Rosand J, Goldstein JN. Using noncontrast computed tomography to improve prediction of intracerebral hemorrhage expansion. Stroke 2023; 54: 567-574.
26)Morotti A, Li Q, Mazzoleni V, Nawabi J, Schlunk F, Mazzacane F, Busto G, Scola E, Brancaleoni L, Giacomozzi S, Simonetti L, Laudisi M, Cavallini A, Zini A, Casetta I, Fainardi E, Dowlatshahi D, Padovani A, Arba F. Non-contrast CT markers of intracerebral hemorrhage expansion: the influence of onset-to-CT time. Int J Stroke 2023; 18: 704-711.
28) Muscas G, Orlandini S, Bonaudo C, Dardo M, Esposito A, Campagnaro L, Carrai R, Fainardi E, Ciccarino P, Della Puppa A. Functional outcomes, extent of resection, and bright/vague fluorescence interface inresection of glioblastomas involving the motor pathways assisted by 5-ALA. Acta Neurochir 2022; 164: 3267-3274.
75)Casetta I, Fainardi E, Saia V, Pracucci G, Padroni M, Renieri L, Nencini P, Inzitari D, Morosetti D, Sallustio F, Vallone S, Bigliardi G, Zini A, Longo M, Francalanza I, Bracco S, Vallone IM, Tassi R, Bergui M, Naldi A, Saletti A, De Vito A, Gasparotti R, Magoni M, Castellan L, Serrati C, Menozzi R, Scoditti U, Causin F, Pieroni A, Puglielli E, Casalena A, Sanna A, Ruggiero M, Cordici F, Di Maggio L, Duc E, Cosottini M, Giannini N, Sanfilippo G, Zappoli F, Cavallini A, Cavasin N, Critelli A, Ciceri E, Plebani M, Cappellari M, Chiumarulo L, Petruzzellis M, Terrana A, Cariddi LP, Burdi N, Tinelli A, Auteri W, Silvagni U, Biraschi F, Nicolini E, Padolecchia R, Tassinari T, Filauri P, Sacco S, Pavia M, Invernizzi P, Nuzzi NP, Marcheselli S, Amistà P, Russo M, Gallesio I, Craparo G, Mannino M, Mangiafico S, Toni D; Italian Registry of Endovascular Treatment in Acute Stroke. Endovascular thrombectomy for acute ischemic stroke beyond 6 hours from onset: A real-world experience. Stroke 2020; 51: 2051-2057.
